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Purpose and Audiences 
This Technical Assistance Publication (TAP)
describes the core elements of screening, brief
intervention, brief treatment, and referral to 
treatment (SBIRT) programs and provides
general administrative and managerial
information relevant to implementing SBIRT
services, including: 
• SBIRT effectiveness. 
• Implementation models. 
• Challenges and barriers to
implementation. 
• Issues of cost and sustainability. 
• Real-life program anecdotes and case
studies. 
The TAP does not address clinical issues in 
implementation; Appendix B includes sources
of information about clinical models. 
Primary audiences for this TAP are healthcare
providers and administrators (including those
in educational institutions) and governmental
and private entities interested in integrating
SBIRT programs into systems of care (e.g.,
State prevention or treatment systems,
hospital systems, community healthcare
systems, primary care practices). Secondary
audiences include Addiction Technology
Transfer Centers, Single State Agencies, and
State mental health and substance abuse
program directors. 
Background 
The SBIRT model represents a paradigm
shift in substance use and abuse 
interventions. Traditionally, interventions
have focused on individuals who have 
severe substance use or those who meet the 
criteria for substance abuse or dependence
as defined by the Diagnostic and Statistical 
Manual of Mental Disorders, Fourth Edition, 
Text Revision (DSM-IV-TR; American
Psychiatric Association [APA], 2000). The
SBIRT model provides for services on a full
continuum of substance involvement. In 
addition to providing for specialty substance
use disorder (SUD) treatment, SBIRT also
targets people who do not yet meet criteria
for an SUD and provides effective strategies
for early intervention before the need
develops for more extensive or specialized
treatment. In fact, many such individuals
may never meet the criteria for substance
abuse or dependence, but they may still
place themselves and others at risk for harm
because of excessive substance use (e.g., binge
drinking). The Centers for Disease Control
and Prevention (CDC) estimates that in 2001,
approximately 76,000 deaths in the United
States were attributable to the excessive use 
of alcohol (CDC, 2004). 
SBIRT is a comprehensive, integrated
public health model designed to provide
universal screening, secondary prevention
(detecting risky or hazardous substance use
before the onset of abuse or dependence),
early intervention, and timely referral and
treatment for people who have SUDs (Babor
et al., 2007; Babor & Higgins-Biddle, 2001;
Substance Abuse and Mental Health Services 
Administration [SAMHSA], 2011). One of
the strengths of the SAMHSA SBIRT model
is that it screens all patients regardless of
an identified disorder, allowing healthcare
professionals in a variety of settings to
address the spectrum of such behavioral
health problems even when the patient is not
actively seeking an intervention or treatment














Systems-Level Implementation of Screening, Brief Intervention, and Referral to Treatment 
SAMHSA supports a research-based
comprehensive behavioral health SBIRT
model that reflects the six following
characteristics (SAMHSA, 2011): 
• 	 It is brief . The initial screening is
accomplished quickly (modal time about
5–10 minutes), and the intervention
and treatment components indicated by
the screening results are completed in
significantly less time than traditional
substance abuse specialty care. 
• 	 The screening is universal . All 
patients, clients, students, or other target
populations are screened as part of the
standard intake process. 
• 	 One or more specific behaviors are
targeted . The screening tool addresses
specific problematic behaviors or behaviors
that are preconditional to substance abuse
or dependence. 
• 	 The services occur in a public health,
medical, or other non-SUD treatment 
setting . The settings include, for example,
emergency departments (EDs), primary
care physicians’ offices, and schools. 
•	 It is comprehensive . The program
includes a seamless transition between 
brief universal screening, a brief
intervention (BI) and/or brief treatment
(BT), and referral to specialty SUD care. 
•	 Strong research or substantial
experiential evidence supports the 
model . At a minimum, programmatic
outcomes demonstrate a successful 
approach. 
As a comprehensive or model approach,
SBIRT has been demonstrated to be 
effective only for risky alcohol use. There is
substantial evidence for the effectiveness 
of BIs for harmful drinking when delivered
by a physician or other qualified health
professional (Bien, Miller, & Tonigan,
1993; Kahan, Wilson, & Becker, 1995; 
Wilk, Jensen, & Havighurst, 1997). There
is a growing body of literature showing the
effectiveness of SBIRT for risky drug use,
but the results vary by the characteristics 
of the provider, the specific setting, and the
patient population that is targeted for SBIRT
implementation. Some studies have found
SBIRT to be quite effective (Bernstein et al.,
2005; Madras et al., 2009), while others have
found mixed results (Humeniuk, Dennington,
& Ali, 2008). 
However, it should be noted that most of the 
SBIRT research addresses only the screening
and BI components of the model. Research
regarding the efficacy and cost effectiveness
of the RT component of SBIRT is still lacking.
When research cited in this TAP addresses 
only some of the components of the model, the
components are specified in the text. 
Although SBIRT interventions are
increasingly recognized as a necessary
approach to addressing public health, they
are not yet fully integrated into healthcare
systems. In October 2003, SAMHSA’s Center
for Substance Abuse Treatment (CSAT) began
its SBIRT Initiative. This initiative promotes
widespread adoption of SBIRT within systems
of medical care as well as education about how
SBIRT works in these settings. 
SAMHSA’s SBIRT Initiative 
The SAMHSA SBIRT Initiative provides
grants and support through three basic 
avenues: 
• Colleges and universities 
• Medical residency programs 
• State cooperative agreements 
Colleges and Universities 
In 2005, SAMHSA’s CSAT awarded Targeted
Capacity Expansion Campus Screening and
Brief Intervention Grants to 12 colleges and
universities to combat underage drinking and
substance use. The grants provided funds to
colleges and universities to initiate or expand
campus-based medical services and to include
SBIRT services for students with hazardous 
drinking and other SUDs through student
healthcare services. 
Chapter 1―Introduction 
Medical Residency Programs 
SAMHSA initiated the Medical Residency
Program in 2008 to develop and implement
SBIRT training programs for medical
residents in diverse medical settings (e.g.,
hospitals, EDs, outpatient clinics, Federally
Qualified Health Centers). Grantees are
developing both online and live training
curricula focusing on SUDs, medical issues
related to those disorders, and principles
and implementation of SBIRT. In addition
to providing didactic training, grantees
are implementing experiential approaches,
including role-plays, supervised practice,
and mentoring programs. A list and brief
profiles of medical residency grantees are
on the SAMHSA SBIRT Web site at http://
www.samhsa.gov/prevention/sbirt/grantees/
medres.aspx. 
State Cooperative Agreements 
As of 2011, SAMHSA has funded 24 SBIRT 
State cooperative agreements in 4 groups
(referred to as cohorts): 
• Cohort 1 (6 State grantees and 1 tribal
council grantee) in 2003 
• Cohort 2 (4 State grantees) in 2006 
• Cohort 3 (4 State grantees) in 2008 
• Cohort 4 (8 State grantees and 1 territorial
grantee [American Samoa]) in 2011 
A list of State grantees (by cohort) is in
Appendix C. 
SAMHSA’s cooperative agreements have
demonstrated how SBIRT can be integrated
effectively into a variety of systems. Some
grantees (e.g., California, Illinois, Texas,
Washington) focused on EDs and trauma
settings. Other grantees (e.g., Pennsylvania)
used funds to implement SBIRT in
community health clinics and primary care
offices. Others (e.g., Colorado, Massachusetts,
New Mexico, Wisconsin) developed SBIRT
programs in a range of settings and
populations statewide. Several State grantees
developed SBIRT programs for specific 
target populations (e.g., adolescent, rural,
and ethnic populations in New Mexico; rural
and ethnic populations in Colorado; native
populations in the Cook Inlet Tribe [Alaska];
elderly population in Florida). 
Grantees implemented SAMHSA-funded 
SBIRT services in a range of healthcare
settings, including inpatient, ED,
ambulatory, primary, and specialty
healthcare settings, as well as community
health clinics. Diverse patient populations
(e.g., Alaska Natives, American Indians,
African Americans, Caucasians, Hispanics)
have been and continue to be screened and 
offered risk-based levels of intervention 
BI, BT, or RT). Grantee programs screen
patients for both illegal drug use and problem
alcohol consumption. Patients with a positive
screening result are determined to need BI,
BT, or RT. 
As part of the SBIRT Initiative, SAMHSA
conducted a cross-site evaluation of cohort 1’s 
grantee programs. Brief profiles of cohort 1
programs are presented in Appendix D. 
Cohort 1 Cross-Site Evaluation 
The cohort 1 cross-site (C1) evaluation, the
most comprehensive assessment of SBIRT to
date, has been completed. Cohort 1 grantees
implemented SBIRT programs in 118 sites.
Between October 2005 and February 2009, the
programs screened more than 658,000 patients. 
The C1 evaluation comprised four 
components: 
• A process evaluation answered questions
about the implementation of SBIRT
across cohort 1 grantees—including
models used, consistency with research
literature, and barriers to and facilitators 
of implementation. 
• An outcome evaluation provided
information on the impact of SBIRT on
substance use and other health-related 
outcomes. 
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Evaluation 
Component 
Data Collection Techniques 
Process • Document review (e.g., proposals, annual and quarterly reports, service delivery materials) 
• Services Accountability Improvement System (SAIS) Government Performance and Results Act 
(GPRA) data 
• In-person and telephone interviews with key stakeholders, program administrators, and  
direct-service practitioners 
• 2 onsite visits to 25 selected sites 
• 198 direct observations 
Outcome • Document compilation and review (e.g., followups to the patient survey by computer assisted 
telephone interviews) 
• SAIS/GPRA patient data—three types of patient-level data were entered into the database: 
baseline characteristics (assessed via a structured interview conducted by SBIRT program staff), 
discharge information regarding service utilization for patients who screened positive for alcohol or 
drugs, and 6-month followup status for a random subset of patients for whom BI, BT, or RT services 
were recommended 
• Surveys of 2,210 randomly selected patients using the Alcohol, Smoking and Substance 
Involvement Screening Test (ASSIST) 
• Surveys of 88 practitioners 
Economic • 6 site visit interviews 
• 7 observational visits 
• Substance Abuse Services Cost Analysis Program (Zarkin, Dunlap, & Homsi, 2004) 
• An economic evaluation provided cost
and cost-benefit information on SBIRT 
interventions. 
• A systemwide evaluation examined the
impact, implementation, and sustainability
of SBIRT across systems and settings. 
In the outcome evaluation, 2,210 unique
baseline interviews were completed with
patients who received SBIRT services
at 31 cohort 1 sites (an average of 71
patients per site). Of the total baseline
sample, 865 patients (39 percent) screened
positive for some level of problem alcohol
or illegal substance use. Of these patients,
511 (59 percent) were categorized for BIs,
170 (20 percent) for BTs, and 184 (21
percent) for referral to more intensive
specialty treatment. The evaluation used
a multimethod approach to capture data
(Exhibit 1-1). 
Overall, the C1 evaluation team found that: 
• SAMHSA SBIRT grantees implemented
SBIRT using evidenced-based practices
and maintained a high level of fidelity. 
• 	 SBIRT was associated with significant
reductions in substance use (i.e., drugs and
alcohol; as much as a 27-percent reduction 
for high-risk patients who received BI, BT,
or RT) and a reduction in associated harms
(e.g., driving under the influence of drugs
or alcohol). 
• SBIRT appears to be an economically
viable strategy for reducing substance use
(i.e., alcohol and drugs) and its associated
harms. 
• SBIRT is sustainable.
 
Final data from the evaluation, along with

some preliminary findings from cohorts 2
and 3 and from the college and university
grantees, inform this TAP. Unless otherwise
indicated, SAMHSA SBIRT Initiative data 
are from as-yet-unpublished reports. These
sources are not formally cited in the text. 



















Several concepts and terms used in this TAP
can have different meanings in different
contexts. For clarity’s sake, these concepts
and terms, as used in this TAP to describe 
SBIRT interventions, are defined as follows: 
Binge drinking means drinking so much
within about 2 hours that the level of blood 
alcohol concentration increases to 0.08g/dL.
This may occur after 4 drinks for women and
after 5 drinks for men (National Institute on
Alcohol Abuse and Alcoholism [NIAAA], n.d.). 
Excessive alcohol use includes binge drinking
(see definition above), heavy drinking (an
average of more than one drink per day for
women or more than two drinks for men), any
alcohol use by pregnant women, and any alcohol
use by people under the age of 21 (CDC, 2012). 
Generalist refers to medical staff and can 
include doctors, nurses, and physician
assistants. 
Harmful drinking refers to a pattern of
alcohol consumption that results in negative
consequences (i.e., to the individual’s physical
and mental health or to society) (Babor,
Higgins-Biddle, Saunders, & Monteiro, 2001). 
Hazardous drinking means that a person
drinks more than the recommended 
consumption limits. NIAAA (n.d.) defines
these limits as 4 standard drinks on any
single day AND no more than 14 standard
drinks per week for men and 3 standard
drinks on any single day AND no more than 7
drinks per week for women. 
Risky alcohol use refers to any alcohol use that
increases the probability of harm (e.g., physical,
mental, social) occurring because of drinking. 
Specialist refers to a substance abuse 
treatment provider, mental health
professional, social worker, or someone
specifically trained to provide SBIRT services. 
Substance dependence (drugs and alcohol) is
a pattern of substance use at any time within 
a 12-month period that is characterized by
three or more of the following symptoms
(DSM-IV-TR, APA, 2000): 
• Tolerance (i.e., a need for increased
amounts of the substance to reach the 
desired effect OR experiencing less of an
effect with the use of the same amount of
the substance) 
• Withdrawal 
• More of the substance was used than 
intended 
• A desire to cut down or control the 
substance use (without success) 
• Spending a lot of time obtaining the
substance, using the substance, or
recovering from using the substance 
• Life activities are reduced (or given up)
because of substance use 
• Substance use continues in spite of
knowing that it is causing physical or
psychological problems 
Provider refers to any professional who treats,
diagnoses, or assesses people to improve or
promote their health. This includes both
medical and nonmedical personnel. 
Patient refers to anyone who receives SBIRT
services from a medical, specialty, or other
type of provider. 
C1 evaluation refers to the cohort 1 cross-site 
evaluation. 
Organization of the TAP 
Chapter 2 provides an overview of SBIRT. It
describes SBIRT components, briefly outlines
the evidence that supports SBIRT’s efficacy,
and provides highlights of SAMHSA’s SBIRT
Initiative. Chapter 3 discusses options for
implementing SBIRT, including settings and
staffing models, and provides information
on implementing SBIRT components.
Chapter 4 describes key implementation and
sustainability issues, and Chapter 5 provides
case studies from SBIRT grantee programs. 
5 
PAGE INTENTIONALLY LEFT BLANK
 
7 
Chapter 2—SBIRT Overview 
Defining Screening, Brief 
Intervention, Brief Treatment,  
and Referral to Treatment 
Over the past decade, substance abuse
services policy has tended toward a more
unified, integrated system that combines
prevention and treatment. Providers and
researchers increasingly recognize that
prevention entails more than discouraging
use—it can include any effort to prevent
negative consequences (e.g., auto crashes,
health problems, unemployment,
homelessness) that result from harmful
drug or alcohol use, as well as attempts to 
prevent hazardous use from progressing to
dependence. Effective intervention efforts
need to be helpful to a wide spectrum of
people, from those who occasionally misuse
alcohol or drugs to those who are severely
dependent. 
A primary aspect of screening, brief
intervention, brief treatment, and referral 
to treatment (SBIRT) is the integration and
coordination of screening and treatment
components into a system of services that
provides a needed intersection between
specialty treatment and prevention (Exhibit
2-1). 
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Screening 
Screening is a process of identifying patients
with possible substance misuse or abuse
problems and determining the appropriate
course of future action for these individuals. 
The screening process does not exactly
identify what kind of problem a person might
have or how serious it might be; screening
simply determines whether a problem exists
or whether further assessment is needed. 
Screening should be conducted using a
validated brief instrument to classify a
patient’s pattern of alcohol or drug use. In
the past, screening instruments were used
to identify active cases of alcohol and drug
dependence, but in recent years, screening
use has expanded to identify individuals
across the full spectrum of use––from risky
substance use to alcohol or drug dependence.
Screening provides healthcare professionals
the opportunity to initiate discussions with
patients about their alcohol and drug use and
to provide intervention as needed. 
Patients who indicate little or no risky
behavior and have a low screening score may
not need an intervention, but they may still
benefit from primary or universal prevention
activities for maintenance of nonrisky use.
Those who have moderate risky behaviors
and/or reach a moderate threshold on the
screening instrument may be referred to
brief intervention. Patients who score high
may need either a brief treatment or further
diagnostic assessment and more intensive,
long-term specialty treatment. 
Screening typically takes 5–10 minutes
and can be repeated at various intervals as
needed to determine changes in patients’
progress over time, depending on the
setting. Some commonly used screens for
the implementation of SBIRT for alcohol
and drug use are the Alcohol Use Disorders
Identification Test (AUDIT; Babor,
Higgins-Biddle, Saunders, & Monteiro, 2001), 
the Drug Abuse Screening Test (DAST;
Skinner, 1982), the Alcohol, Smoking and
Substance Involvement Screening Test
(ASSIST; Humeniuk, Henry-Edwards, Ali,
Poznyak, & Monteiro, 2010), the Cut Down, 
Annoyed, Guilty, Eye-Opener (CAGE; Ewing,
1984), and the National Institute on Drug
Abuse (NIDA) Drug Use Screening Tool (see
Appendix E). In addition, recent studies have
found a single question related to alcohol or
drug use to be effective in detecting alcohol
use (Smith, Schmidt, Allensworth-Davies, 
& Saitz, 2009) or drug use (Smith, Schmidt,
Allensworth-Davies, & Saitz, 2010) among 
primary care patients. 
Brief Intervention 
Brief intervention (BI) is appropriate for
patients identified through screening to
be at moderate risk for substance use 
problems. BI can be provided through a single 
session or multiple sessions of motivational
interventions (see Appendix B for more
information on motivational interventions).
These interventions focus on increasing a
patient’s insight into and awareness about
substance use and behavioral change. BI
can be tailored to a particular population or
setting. It can be a stand-alone treatment
for those at risk or a vehicle for engaging
those in need of more intensive levels of care. 
BI typically is provided at the same site as
screening. 
The majority of patients report minimal or no
problems with alcohol or drugs and as such
may be candidates for primary or universal
prevention activities for maintenance of
nonrisky use or abstinence. With respect
to alcohol use, in general only a small
proportion (3 to 5 percent) of patients in
primary care settings screen positive for
alcohol dependence (Babor & Higgins-Biddle, 
2001). However, levels for hazardous and
harmful drinking range from 15 to 40 percent
of the population (Babor & Higgins-Biddle,
2001). The goal of a BI (which usually
involves one to five sessions lasting about
5 minutes to 1 hour) is to educate patients
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Brief Treatment 
Brief treatment (BT) (sometimes called
brief intensive intervention) is a specialty
outpatient treatment modality. BT is a
systematic, focused process that relies
on assessment, patient engagement, and
implementation of change strategies. The goal 
of BT is to change not only the immediate
behavior or thoughts about a risky behavior
but also to address long standing problems
with harmful drinking and drug misuse and
help patients with higher levels of disorder
obtain more intensive care. The treatment 
consists of assessment and a limited 
number (typically 6 to 20) of evidence-based, 
highly focused, and structured clinical
sessions (e.g., solution-focused therapy, 
cognitive–behavioral therapy, motivational
enhancement) to help patients address
unhealthy cognitions and behaviors
associated with current use patterns and
adopt change strategies. Patients may
receive BT onsite but more commonly are
referred to an outside program or another
component of a medical system. One
potential challenge to implementation is
that substance use disorder (SUD) clinicians
trained in traditional long-term approaches
are sometimes resistant to or not well trained 
in structured brief approaches. 
Although the time required to execute either
BI or BT is generally considered brief, they
are often considered too lengthy for primary
care providers to perform. Also, providers
cite concerns about angering or insulting
patients by bringing up sensitive issues
such as alcohol and drug use. Although
these concerns are understandable, when 
SBIRT is implemented properly, the time
commitment is reasonable and acceptably low
given the demonstrated success in identifying
persons requiring referral to treatment.
Similarly, concerns about patient reactions
can be neutralized by proper training for the
providers and ensuring that access to referral
services is available. In addition, SBIRT is 
frequently implemented by allied health
professionals such as nurses, social workers,
or health educators, with results and actions 
noted in the patient chart for primary care
provider notification and oversight. 
Patients referred to a BT often have higher
risk factors than those referred to a BI. If 
patients report greater risk factors than BT
can address, they are referred to specialty
SUD care. In some cases, a patient may
receive a BI first and then move on to a BT or 
longer-term care. 
Referral to Treatment 
Patients identified as needing BT or more
intensive treatment than BI are referred 
to specialty SUD treatment providers. The
primary goals of referral to treatment (RT)
are to identify an appropriate treatment
program and to facilitate engagement of the
patient in treatment. RT can be a complex
process involving coordination across
different types of services. It requires a
proactive and collaborative effort between
SBIRT providers and those providing
specialty treatment to ensure that a patient,
once referred, has access to and engages in
the appropriate level of care. To facilitate
patient engagement, SBIRT providers may
use motivational enhancement techniques to
help patients with any ambivalence toward
treatment, provide transportation to intake
appointments, follow up with patients after
an appointment, and maintain contact with
the specialty treatment provider. 
The absence of linkages to treatment referrals
can be a significant barrier to the adoption
of SBIRT. Referral is recommended when 
patients meet the diagnostic criteria for
substance abuse or dependence (or SUD)
or other mental illnesses, as defined by the 
Diagnostic and Statistical Manual of Mental
Disorders, Fourth Edition, Text Revision 
(DSM-IV-TR). For patients in primary care
settings, the lack of a proper treatment
referral will prevent access to appropriate and
timely care that can affect other psychosocial
and medical issues. Research findings suggest
that motivational-based BIs can increase 
patient participation and retention in SUD
treatment (Dunn & Ries, 1997). 
9 
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Strong referral linkages are critical, as is
tracking these patient referrals (Hillman,
McCann, & Walker, 2001). The Substance
Abuse and Mental Health Services 
Administration (SAMHSA) requires SBIRT
grantees to have a comprehensive RT and
followup system in place for the duration
of the program. In the case where RT is
incorporated into an integrated care model,
this incorporation may require shifts in
provider allocation and hiring. 
The SBIRT Process 
Exhibit 2-2 provides a chart of the SBIRT 
process. 
Exhibit 2-2. SBIRT Process 
Screening 
Brief Treatment 












DependenceModerate RiskNo or Low Risk 
The process can also include changes in
level or intensity of care if a patient needs
a different intervention. Screening can be
repeated at intervals, as needed. 
The following characteristics have formed the
foundation for the SAMHSA SBIRT programs
for identifying behavioral health problems: 
• 	 SBIRT uses brief, validated, universal 
prescreening/screening tools . These 
tools allow healthcare professionals
to address the problem behavior even
when the patient is not actively seeking
treatment for the problem. Prescreening/
screening tools accurately and quickly
identify individuals with problematic
conditions in as little time as 2–4 minutes. 
Because of its briefness and its universal 
application (i.e., it can be used with all
patients), SBIRT may be more generally
accepted by busy healthcare providers. 
•	 SBIRT is relatively easy for diverse
providers to learn . The SBIRT approach
is easy to learn relative to other behavioral
treatment techniques that may require
lengthy specialized training. Therefore, it
can be implemented by various healthcare
providers such as physicians, nurses,
social workers, health educators, and 
paraprofessionals who work in busy
medical settings. 
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Prescreening 
Prescreening, which is not a core component of SBIRT but is frequently used, reduces the time 
needed by busy clinic staff to identify patients with risky behavior. Some grantee programs added a 
prescreening component to adapt SBIRT to accommodate their real-world circumstances. Prescreening 
using an abbreviated screening tool allows staff to triage patients quickly to additional screening or 
necessary treatment services, depending on responses. Babor et al. (2007) concluded that shortened 
screening approaches may facilitate healthcare providers’ implementation of SBIRT services because 
they require less time to administer than do standard screening approaches. Shorter approaches 
eliminate a commonly cited time barrier to SBIRT implementation. 
Few prescreening tools for alcohol and illicit drug use have been validated. One validated tool is the 
Alcohol Use Disorders Identification Test—Consumption (AUDIT-C), which uses the first three alcohol 
consumption questions of the full, 10-item AUDIT questionnaire (Bradley et al., 2007). Other useful tools 
include the National Institute on Alcohol Abuse and Alcoholism (NIAAA) prescreening question (“How 
many times in the past year have you had 5 drinks or more in a day [for men] OR 4 or more drinks in a 
day [for women]?”; NIAAA, 2005), the one-question prescreening tool for illicit drug use (“How many 
times in the past year have you used an illegal drug or used a prescription medication for nonmedical 
reasons?”; Smith et al., 2010, p. 1155), and the NIDA Drug Use Screening Tool (see Appendix E for more 
information about screening tools). If a patient scores high on any domain in the prescreen, a full screen 
is conducted. 
• 	 SBIRT incorporates a strong
referral component to link patients 
to specialty treatment . Effective 
approaches integrate comprehensive
strategies that include referral to
specialty treatments (Babor et al.,
2007). Although RT may be difficult in
underserved areas, this should not deter 
programs from developing screening
and BI (SBI) activities because they
have beneficial effects separate from the
referral (i.e., even short conversations
with a healthcare professional can
reduce a patient’s substance use [Babor
et al., 2007]). However, the goal of the
RT component is to provide a quick
handoff of patients to specialty SUD
treatment if the screening site cannot
provide more intensive SUD services. The
availability of well-established referral 
linkages to specialty care is essential to
the implementation and maintenance of
SBIRT. In addition, monitoring patient
compliance with SUD treatment is critical
to good healthcare provision. 
Why SBIRT? The Problem 
According to the 2011 National Survey on
Drug Use and Health (NSDUH; SAMHSA, 
2012), more than 19 million people (7.5
percent of those ages 12 and older) were
in need of but did not receive specialty
treatment in the past year for illicit drug or
alcohol use problems. The vast majority of
these individuals (95 percent) believed they
did not need treatment. Of those who believed 
they needed treatment, only 30.8 percent
made an effort to obtain treatment. 
The health and economic costs of substance 
abuse are considerable—not only for
the individuals involved but also for the 
healthcare system. A study on the costs of
excessive alcohol consumption estimated
that the total cost of excessive drinking
in the United States was $223.5 billion in 
2006 (Bouchery, Harwood, Sacks, Simon, &
Brewer, 2011), a 21-percent increase from
the $184.6 billion in 1992 (Harwood, 2000).
The National Drug Intelligence Center (2011)
estimated that the cost of illicit drug use (in
the United States) was $193 billion. 
Medical conditions are more common 
among patients with SUDs than among
those without those disorders (Mertens, Lu,
Parthasarathy, Moore, & Weisner, 2003).
Substance abuse has been associated with 
higher levels of numerous medical conditions, 





including cancer, cardiovascular disease,
gastrointestinal disorders, infectious diseases, 
and hepatic disorders. A disproportionate
percentage of the burden for treating
substance abuse and its consequences
increasingly falls on public institutions. 
Why SBIRT? Benefits and Efficacy 
If only people with the most extreme alcohol
and drug use problems are recognized as
being in need of treatment, people who
misuse substances but do not meet the 
criteria for an SUD are not identified. SBIRT 
provides a systematic means of identifying
and providing appropriate services to people
who clearly need but are not receiving
treatment and those who use substances but 
do not meet SUD criteria. Equally important,
SBIRT may prevent problems. The model
applies an “upstream” approach; it attempts
to identify and intervene in substance
misuse before an SUD develops. The Office
of National Drug Control Policy (ONDCP)
(2011) stated that: 
It is critical for medical professionals to be
able to identify the early signs of substance
abuse in their patients and to intervene
early. These early interventions can result
in savings to the healthcare system and,
most important, saves lives. SBIRT is a
tool that enables healthcare professionals
to ask patients about substance use
during routine medical visits. SBIRT helps
healthcare providers identify individuals
with problems related to substance use,
provide medical advice to help patients
who have been identified as having risky
substance use to understand the related 
health risks and consequences, and refer
patients with more severe substance
use-related problems to treatment. (p. 27) 
The evidence supporting the effectiveness of
BI suggests that even short conversations
with a healthcare professional (e.g., nurse,
physician assistant, physician) can reduce a
patient’s substance use (Babor et al., 2007).
For example, BIs are effective in reducing 
risky and harmful alcohol use by adult
primary care patients (men and women)
(Whitlock, Polen, Green, Orlean, & Klein,
2004). Svikis and Jones (2005) found that
screening pregnant women for smoking was
a useful way to identify women who were at
risk for alcohol and drug use. BIs for patients
screening positive for cocaine, heroin, and
amphetamine are also showing promising
results in various settings (Cunningham et
al., 2009). With prescription drugs being the
second most prevalent category of illicit drug
use (second only to marijuana) (SAMHSA,
2012), many are advocating for SBIRT
(for prescription drug abuse) to be taught
to healthcare providers as part of their
education, either in medical school (Brown,
Swiggart, Dewey, & Ghulyan, 2012; Rasyidi,
Wilkins, & Danovitch, 2012) or through
continuing education courses (Swiggart,
Ghulyan, & Dewey, 2012). 
Alcohol Misuse, Abuse, and Prevention 
Several studies have found SBIRT to be 
effective for those who misuse alcohol. 
Based on a review of the literature, the U.S. 
Preventive Services Task Force (USPSTF)
found “good evidence that screening in
primary care settings can accurately identify
patients [including pregnant women] whose
levels or patterns of alcohol consumption do
not meet criteria for alcohol dependence, but
place them at risk for increased morbidity
and mortality” (USPSTF, 2004, p. 1). 
The USPSTF review also noted that: 
• Brief behavioral counseling interventions
(with followup) can lead to small
to moderate reductions in alcohol 
consumption. 
• These reductions are sustained for 1 year
or longer. 
• If screened for alcohol abuse using a
validated instrument, between 8 and 18 
percent of general primary care patients






Chapter 2―SBIRT Overview 
Combined study results in the USPSTF (2004)
review suggest mean reductions in alcohol
consumption that ranged from 3 to 9 drinks
per week (13- to 34-percent net reduction in
drinking) in the intervention groups compared
with the control groups at 6- and 12-month
followups. Of the participants who received
interventions in primary care, between 10 and
19 percent more participants stopped drinking
at harmful or risky levels than did the
individuals who did not receive interventions. 
Research also indicates that, despite the
robustness of the evidence for SBIRT’s 
effectiveness for unhealthy alcohol use,
other factors can influence its effects. For 
example, studies have shown that multiple
contacts or sessions (in contrast to a single
contact) with a provider can increase the
impact of SBIRT in reducing risky alcohol
consumption (Brown, Saunders, Bobula,
Mundt, & Koch, 2007; Longabaugh et al.,
2001). Moreover, demographic factors and
psychosocial conditions (e.g., medical illness
or hospitalization) also have been shown to
influence SBIRT’s effects on alcohol misuse 
(Saitz, Svikis, D’Onofrio, Kraemer, & Perl,
2006). 
The conduct of SBIRT for alcohol use 
disorders has been found to be effective in 
various healthcare settings for diverse patient
populations including primary care (Babor
et al., 2007), emergency departments (EDs),
(Gentilello et al., 1999), and schools and
colleges (Baer, Kivlahan, Blume, McKnight,
& Marlatt, 2001; Dimeff, Baer, Kivlahan, 
& Marlatt, 1999). Data are currently being
collected that suggest that SBIRT may also
be effective in addressing alcohol problems
in employee assistance programs (Goplerud
& McPherson, 2010; McPherson et al., 
2009). Research also has demonstrated the
efficacy of conducting SBIs using innovative
strategies, such as the use of personalized
feedback via the Internet (Cunningham et al.,
2009) and the use of Web-based programs to 
monitor patient outcomes and to assist with
making treatment decisions (Roy-Byrne et al., 
2010). Gentilello et al. (1999) found that brief
interventions at a regional trauma center 
resulted in reduced alcohol consumption.
Patients in the intervention group with
intermediate Michigan Alcohol Screening
Test (MAST; Selzer, 1971) scores experienced
an alcohol consumption reduction of 21.6
percent from baseline to 12 months. This
group of patients also had a 47-percent 
reduction in new injuries requiring ED
treatment and a 48-percent reduction in new 
injuries that required hospital readmission. 
Research on the efficacy of SBIRT for
patients admitted to medical facilities is
limited, and the results are mixed (Emmen,
Schippers, Bleijenberg, & Wollersheim,
2004). Saitz et al. (2007) found that BIs
with hospital patients were not sufficient for
linking medical inpatients who had alcohol
dependence with appropriate treatment and
that BI had no effect on patients’ level of
alcohol consumption. They concluded that
these patients needed more extensive and
tailored interventions. 
The use of computerized interventions has
been shown to be effective in augmenting and
complementing the gains made through the
initial face-to-face brief interventions. The 
Department of Veterans Affairs, for example,
examined the use of electronic reminders 
placed in patients’ electronic medical records
to encourage providers to offer brief alcohol
counseling to patients who screened positive
for unhealthy alcohol use on the AUDIT-C. 
These reminders were associated with 
moderate drinking reductions at followup
(Williams et al., 2010). Other research
reviews indicate that electronic methods can 
improve the effectiveness and accessibility
of SUD treatment by offering online
assessment and feedback tools for patients,
providing tools for providers to monitor
patients’ treatment progress, and providing
educational opportunities for clinicians
(Cucciare, Weingardt, & Humphreys, 2009).
Electronic intervention can also help bridge
the treatment capacity gap by providing
another source of assistance for women who 
do not complete traditional substance abuse
treatment (VanDeMark et al., 2010). 
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The Community Preventive Services Task
Force (CPSTF), an independent, volunteer
body appointed by the Director of the
Centers for Disease Control and Prevention 
(CDC), reviewed 31 studies involving
electronic screenings and brief interventions
(e-SBIs; e.g., telephones and other mobile
devices, computers) to reduce alcohol
consumption. The CPSTF concluded that
e-SBI is applicable to various settings (e.g.,
healthcare, universities) and had positive
effects across various outcomes related to 
alcohol consumption (e.g., binge drinking,
overall consumption) (CPSTF, 2012).
Based on this review, the CPSTF recently
recommended e-SBI as an effective tool for 
reducing alcohol consumption. 
The cost savings offered by the
implementation of the SBI components alone
are significant. One study (Gentilello, Ebel,
Wickizer, Salkever, & Rivara, 2005) showed
that for every $1.00 spent on providing
SBI approximately $3.81 is saved. The
Washington State SBIRT program cost study
also reflects similar savings. Notwithstanding
the potential effectiveness and cost savings,
many opportunities to intervene in patients’
risky alcohol use are lost. A 2003 study found
that although 70 percent of people who smoke
nicotine were advised to quit smoking by a
healthcare provider, only 23 percent of binge
drinkers were asked by a provider to discuss
their alcohol use (Denny, Serdula, Holtzman,
& Nelson, 2003). 
The concept of SBIRT can be applied
across the continuum of care for alcohol 
problems. Based on the severity of the
problem indicated by the screening results,
interventions ranging from universal
prevention to BIs to traditional specialty
treatment can be provided to healthcare
patients. For individuals who are abstinent,
universal prevention practices can be
implemented to sustain alcohol abstinence.
For moderate risky drinking, the first
two components of SBIRT—SBI—may be
implemented and can address inappropriate
expectancies (beliefs about substance use
effects and social norms of acceptable 
behavior) and lack of motivation to change
risk factors that contribute to substance 
abuse (Dimeff et al., 1999). Therefore, SBIs
incorporate motivational interviewing
components (Miller & Rollnick, 2002) that are
also integrated in BT for higher-risk patients. 
SBIs have proven effective in decreasing
overall consumption binge drinking (Babor
et al., 2007; Heather, Dallolio, Hutchings,
Kaner, & White, 2004; Kunz, French, & 
Bazargan-Hejazi, 2004; Martens et al., 2007;
Murphy et al., 2001; Toumbourou et al., 2007)
and increasing productivity (Osilla et al.,
2010). Evidence further demonstrates that
strengthening resiliency, competencies, and
social connectedness supports recovery for
those individuals who show early symptoms
of alcohol misuse. 
Extensive reviews of the effectiveness of 
SBI (Babor, 2008; Babor et al., 2007) have
found that SBI can lead to both short-term 
and long-term health benefits. However,
to achieve long-term effects, SBI must
be implemented with fidelity through
targeted training for providers (Babor,
Higgins-Biddle, Higgins, Gassman, & 
Gould, 2004; Bray et al., 2009; Cameron,
Lee, & Harney, 2010; Christensen, Boisse,
Sanchez, & Friedmann, 2004; Heather et al., 
2004; Seale, Shellenberger, Boltri, Okosun,
& Barton, 2005; Tollison et al., 2008). In
many instances providers implementing
SBI may not necessarily be physicians but
may be allied health professionals such as
nurses, counselors, health educators, and 
peers (Blume & Marlatt, 2004; Mastroleo,
2009), who may experience fewer barriers in
service provision than physicians do (Babor
et al., 2004). Some studies have found even
telephone interventions to be efficacious
(Brown et al., 2007; Oslin et al., 2003). 
Illicit Drugs 
Based on the scant availability of published
research on SBIRT for drug use, USPSTF
(2008) concluded that the evidence regarding
screening for illicit drug use was inadequate
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harms of screening adolescents, adults, and
pregnant women. Some researchers have
cited the relative scarcity of validated brief
drug screening tools (Smith et al., 2010)
and the low prevalence rates of drug use
in primary care settings as two reasons for
the comparatively small number of studies
showing SBIRT’s effects with drug use
(Saitz, 2010). Nevertheless, since 1995,
investigator-initiated SBIRT research has
grown, and findings from SAMHSA-funded
SBIRT projects have emerged. As a whole,
the work shows promising results for the use
of the comprehensive SBIRT approach (and
the selected use of individual components)
in reducing risky drug use (Copeland, Swift,
Roffman, & Stephens, 2001; Madras et al.,
2009). For instance, a randomized controlled
trial indicated that BIs can reduce cocaine 
and heroin use (Bernstein et al., 2005).
Motivational interviewing coupled with a
self-help booklet given to people who use 
amphetamine regularly also resulted in
reduced levels of drug use (Baker et al.,
2005). SBIs have been linked with reductions
in the use of marijuana, amphetamine-type 
stimulants, cocaine, and heroin (Madras
et al., 2009; see the next section, SAMHSA 
SBIRT Grantees, for more information).
In a study sponsored by the World Health
Organization, Humeniuk et al. (2008)
found that SBIs resulted in short-term 
reductions in the use of a wide variety of
illicit drugs, including marijuana, cocaine,
amphetamine-type stimulants, and opioids. 
SBIRT is also a key component of the 2011
and 2012 National Drug Control Strategy
(ONDCP, 2011, 2012a). 
Universal and selective prevention efforts
may be targeted to those with minimal or
mild drug misuse—just as they are with those 
who abuse alcohol—and identified abstainers 
can benefit from supportive and normative
information to maintain healthy lifestyles.
For individuals at risk for drug problems,
early identification and BIs that address
false expectancies and skill acquisition can
prevent progression to more severe drug
problems. In addition, tools that can be used
for universal screening of drug use in health 
settings—such as the DAST and the ASSIST
as well as online tools such as eCHECK UP 
TO GO (eCHUG), the electronic THC Online
Knowledge Experience (e-TOKE; San Diego
State University Research Foundation, 2009–
2012), and the NIDA Drug Use Screening
Tool (see Appendix E)—are prevention-ready 
applications designed to detect the presence
of drug use. 
SAMHSA SBIRT Grantees 
SAMHSA grantees provide additional
evidence of SBIRT’s effectiveness with both 
alcohol and illegal drug use. For example,
Madras et al. (2009) performed a secondary
analysis of initial SAMHSA SBIRT Initiative
data from the program sites of six State
grantees. Of 459,599 patients screened at the
time of the analysis, 22.7 percent screened
positive for use defined as “risky/problematic”
or “abuse/addiction.” Of the patients who
screened positive: 
• 15.9 percent were recommended for BI. 
• 3.2 percent were recommended for BT. 
• 3.7 percent were recommended for RT. 
A comparison of the rates at the start of
the study (baseline) with rates at 6-month
followup shows that in the majority of cases
self-reported alcohol and drug use rates
diminished from baseline to followup for
those patients reporting heavy alcohol use
and illicit drug use. 
Among patients reporting illegal drug use at
baseline, rates of use at the 6-month followup
were 67.7 percent lower than at baseline,
and heavy alcohol use was 38.6 percent
lower than at baseline. Among persons
recommended for BT or RT, patients not only
reported reductions in criminal behavior,
but also reported significant improvements
in general health, mental health, and
employment and housing status. 
Madras et al. (2009) noted some possible
limitations to the study, particularly the
absence of control groups. Without control
groups, it is possible that the improvements 






noted were unrelated to the interventions. 
However, the authors concluded that SBIRT 
was feasible to implement, and that the
patients’ self-reported status at the 6-month
followup indicated significant improvements
in alcohol or drug use and functional domains
over baseline. They also stated that the
findings were comparable across sites and
gender, racial/ethnic, and age subgroups. 
The final cohort 1 cross-site (C1) evaluation
team found significant decreases in alcohol
and drug use after the intervention. Overall,
an association was found between SBIRT 
participation and reduced substance use as
exhibited by declines in ASSIST substance
use risk scores. Responses to questions on
the ASSIST have a numerical score; added 
together they produce an ASSIST score. A
number of different scores can be calculated 
for the ASSIST, including: 
• The Total Substance Involvement (TSI)
score, which measures global risk for SUDs
across all substances. 
•	 The Specific Substance Involvement score,
which measures risk within particular
drug classes. 
The C1 evaluation team found that total 
substance use risk for all patients who had
positive screening results decreased from an
ASSIST TSI score of about 33 to 29, but this 
decrease was not statistically significant.
However, when patients who were screened
for BI but classified as low risk1 were 
removed from the analysis, the remaining
SBIRT patients who screened positive had a
statistically significant average decrease in
TSI scores, from approximately 52 to 38 (a
27-percent decrease). 
Both the BT and RT groups had more
significant declines in average TSI scores
than either of the BI groups. The TSI score 
for patients receiving BTs fell from 50.2
to 34.4, a significant decrease of about 31
percent. The RT group experienced an even
larger decrease in TSI score, falling from 64.3
to 34.5, a significant decrease of 46 percent. 
The C1 evaluation team also looked at 
changes in use of specific substances, as
measured by the percentage of patients at
6-month followup who reported having used
the substance within the past 3 months
(Exhibit 2-3). 
The C1 evaluation team found that SBIRT’s 
impact on opioid use was not as strong as
its impact on other substance use. In fact,
the percentage of patients reporting any
opioid use actually increased at followup,
although the increase was not statistically
significant. The RT group showed no change.
The BT group was the only group that
showed decreased opioid use (a statistically
significant decrease of 24 percent). 
In addition to measuring changes in
substance use, the C1 evaluation team 
found the following improvements in other
health-related functional domains among 
patients with positive screening results: 
• The percentage of patients receiving
routine preventive care (e.g., physical
examination; routine blood tests; 
screening for hypertension, cancer, cardiac
abnormalities) increased overall. Those
in the low-risk BI group had the biggest
increase (34 percent to 73 percent). 
• The percentage of patients receiving
outpatient medical treatment (e.g.,
treatment in an office or clinic for a 
physical health problem) generally
increased. The RT group had the largest
increase in percentage of patients receiving
outpatient medical treatment (49 percent
to 63 percent). 
1Patients who screened positive but with low TSI scores presented a potential for skewing overall results. A low score left little room 
for score improvement at followup and could not be distinguished clearly from the score of those who screened negative. Patients 
who screened positive but had a low score also were less likely to perceive a need for significant behavior change. To ensure more 
meaningful results, the C1 evaluation team split the BI group into two subgroups: low risk and higher risk. This separation was 
accomplished by determining whether a patient’s baseline TSI was below or above the median TSI score among all individuals 
screened for BI. 
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Exhibit 2-3. C1 Evaluation Results of Patients Reporting Any Substance Use in  
Past 3 Months at 6-Month Followup 
Substance All Groups  
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from 47 to 20 
percent 
The probability of ED use generally
decreased among patients, especially for
those in the BT group and low-risk BI group.
Emergency treatment for these two groups
had statistically significant decreases of
20 percent and 24 percent, respectively.
However, among patients who used ED
services, the number of ED visits increased 
significantly for all those who screened
positive and increased substantially for those
in the RT group. 
Those in the BT and RT groups decreased
their probability of any drinking and driving.
Approximately 36 percent of individuals in
both groups reported driving while under
the influence at baseline. Rates of driving
under the influence decreased substantially
to 18 percent in the BT group (a 50-percent
decrease) and 14 percent in the RT group (a
60-percent decrease). 
Why SBIRT? Cost-Effectiveness/ 
Benefit Cost 
The cost savings of SBIRT vary by screening
instrument, staffing model, and setting.
Cost-benefit analyses suggest that screening 
and brief counseling of risky alcohol use
provide a cost savings of $43,000 in future
healthcare costs for every $10,000 invested
in early intervention (Fleming et al., 2002).
Patients receiving BIs had fewer hospital
days and fewer ED visits. The BI cost $205
per unit—$166 in costs to the clinic and $39
to the patient—and saved $712 in healthcare 
costs. 
A meta-analysis of 15 studies analyzing
cost benefit, cost-effectiveness, and cost 
utility of SBIs for unhealthy alcohol use
found cost-saving benefits when performed 
in medical settings that met or exceeded
standardized preventive care, such as
influenza immunization or colorectal 
screening (Kraemer, 2007). The analysis
demonstrated a strong economic benefit of
alcohol SBI when compared with usual care.
Maciosek et al. (2006) identified the most 
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valuable clinical preventive services that
can be offered in medical settings. Screening
for problem drinking and brief counseling
ranked high among effective preventive
services, based on a combined score of two 
measures—clinically preventable burden and 
cost-effectiveness (Exhibit 2-4). 
Exhibit 2-4. Priorities Among Effective Clinical 
Preventive Services 
Preventive Service Combined 
Score* 
Discussion of daily use of aspirin 10 
Childhood immunization series 10 
Tobacco use screening and BI 10 
Colorectal cancer screening 8 
Hypertension screening 8 
Influenza immunization 8 
Pneumococcal immunization 8 
Problem drinking screening and 
brief counseling 
8 
Vision screening—adults 8 
Cervical cancer screening 7 
*Possible scores ranged from 2 to 10. 
Adapted from Maciosek et al. (2006). 
SBIRT for Other Behavioral 
Health Disorders 
The prevalence of issues such as depression,
anxiety, and emotional trauma among primary
care patients calls for further exploration to
determine whether SBIRT can be adapted
and implemented to address mental disorders
among patients in primary care. 
Although the comprehensive SBIRT model
has been demonstrated to be effective for 
risky alcohol use, it has not been consistently
demonstrated to be effective in addressing
depression, trauma, or anxiety symptoms
or diagnoses. Programmatic data from the
SAMHSA State SBIRT programs show
promising results for identifying and providing
interventions targeting depression among 
primary care patients (Wisconsin Initiative
to Promote Healthy Lifestyles [WIPHL],
n.d.). Public health approaches that are
consistent with the SBIRT model have also
been recommended for tobacco use and are
recognized to be cost effective (Exhibit 2-4). 
Tobacco Use 
Cigarette smoking continues to be the leading
cause of preventable disease and death in the
United States (U.S. Department of Health
and Human Services, 2004) and contributes
to approximately 443,000 deaths per year
(CDC, 2008) from lung cancer, ischemic
heart disease, chronic obstructive pulmonary
disease, strokes, and other diagnoses. In
spite of the well-documented risks of smoking
and the potential health benefits of quitting,
approximately 1.4 million people younger
than age 18 became regular smokers in 2010,
and more than 27 percent of individuals ages
12 or older in the United States continue 
to smoke (SAMHSA, 2012). Smoking also
affects health outcomes of people other than
the smokers, with smoking during pregnancy
resulting in premature births, intrauterine
growth retardation, fetal respiratory
distress, and low infant birth weight (CDC,
2008; USPSTF, 2009a). Secondhand smoke
contributes to the deaths of an estimated 
38,000 people every year (USPSTF, 2009a). 
Research has also shown that mental 
disorders and cigarette smoking are
frequently co-occurring conditions 
(Degenhardt & Hall, 2001; Dome, Lazary,
Kalapos, & Rihmer, 2010; Grant, Hasin,
Chou, Stinson, & Dawson, 2004; Ziedonis 
et al., 2008). A study using data from the
2005–2006 NSDUH reported that adults with
lifetime depression, anxiety, anxiety with
depression, or major depressive episodes were
“more likely to be current smokers, smoke
with higher intensity and frequency, have
more dependence, and have lower success
at quitting” when compared to individuals
without these disorders (Trosclair & Dube,
2010, p. 438). Individuals with serious
mental illness (SMI; e.g., schizophrenia)
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individuals without mental illness (Epstein,
Barker, Vorburger, & Murtha, 2004; Kelly &
McCreadie, 2000), but Banham and Gilbody
(2010) found that treatment for tobacco
dependence can be effective for individuals
with SMI and, if their mental disorders are 
stable, treatment for tobacco dependency
does not worsen their symptoms. Because
70 percent of smokers see a primary care
provider each year (Fiore et al., 2008),
clinicians have a unique opportunity to
intervene and implement tobacco SBIRT in
primary care settings and EDs. 
Consequently, USPSTF (2009a) recommends
that clinicians screen all adults for tobacco 
use and provide interventions for smoking
cessation. USPSTF issued a separate
recommendation that clinicians screen all 
pregnant women for tobacco use and provide
counseling specifically designed for pregnant
women who use tobacco products. 
USPSTF (2009a) recommends that the
clinical interventions for tobacco cessation 
that are cited in the 2008 U.S. Public 
Health Service Clinical Practice Guideline, 
Treating Tobacco Use and Dependence
(Fiore et al., 2008), become integrated in
standard clinical practice. The Guideline
recommends that clinicians use the screening
instrument known as the 5A’s of tobacco use 
intervention, which provides a useful strategy
for engaging all medical patients in smoking
cessation discussions. The 5A’s are consistent 
with the SBIRT approach and parallel the
screening and brief intervention or counseling 
components of the SBIRT model: 
1. Ask about tobacco use. 
2. Advise to quit through clear personalized 
messages. 
3. Assess willingness to quit. 
4. Assist to quit. 
5. Arrange followup and support. 
The guideline’s behavioral treatments include
counseling, social support, problem solving,
and cessation skills training offered in
face-to-face individual or group formats or via 
telephone “quit lines.” Medication-assisted
treatments for tobacco use/dependence have
also been suggested and include several
Food and Drug Administration-approved
medications (Fiore et al., 2008). 
Depression 
USPSTF (2009c) supports depression
screening for adults only when accurate
diagnosis services, effective treatment,
and followup are available. USPSTF also
recommends screening adolescents (12
to 18 years of age) for major depressive
disorder, again when accurate diagnosis,
psychotherapy (cognitive–behavioral or
interpersonal), and followup are available
(USPSTF, 2009b). There are many
commonly used screening tools for depressive
symptoms that have established validity and
reliability data, such as the Patient Health
Questionnaire 9 (PHQ-9; Kroenke, Spitzer,
& Williams, 2001) and the Patient Health
Questionnaire 2 (PHQ-2; Kroenke, Spitzer, &
Williams, 2003). 
Primary care physicians are the providers
most likely to see patients when they first
become depressed, and these providers are
most capable of initiating and monitoring
treatments with pharmacologic agents
(McNaughton, 2009). Previous studies,
however, have shown that at least half of 
patients with active depression seen by
primary care physicians remain undiagnosed
(Ormel, Koeter, van den Brink, & van de
Willige, 1991; Schulberg & Burns, 1988).
Depression is particularly prevalent among
“high utilizers” of medical care, of whom as
many as 40 percent have been found to have a
current depressive illness (Katon et al., 1990). 
Promising but preliminary data are
available from SBIRT grantees funded by
SAMHSA that indicate that the SBIRT
approach may be adapted for depression
treatment. For example, the State of
Wisconsin incorporated depression screening
into the WIPHL pilot program. Patients with
mild or moderate depression were provided
behavioral activation by health educators




using specific protocols developed by the
program (WIPHL, n.d.). 
Behavioral activation offers promise as a
strategy for BI, and there is some evidence
that it would fit an SBIRT-like approach. 
Behavioral activation assists individuals to 
identify and engage in daily activities and
situations they find positively reinforcing
and consistent with their long-term goals
(Dimidjian et al., 2006). Behavioral activation
as a BI has been demonstrated in three 
meta-analyses, one randomized controlled 
trial, and one followup study of a previous
randomized controlled trial to be an effective 
intervention for the treatment of depression
(Sturmey, 2009). 
Anxiety Disorders 
The National Comorbidity Survey Replication
(Kessler et al., 2005) found anxiety disorders
to have the highest percentage of lifetime
prevalence of all the mental disorders in
the United States (28.8 percent), so it is not
surprising that anxiety disorders are among
the most common mental disorders seen in 
primary care settings. One study showed
that 19.5 percent of primary care patients
participating in the study had a current
anxiety disorder, and approximately 33
percent of those patients had more than one
anxiety disorder, with levels of impairment
and healthcare utilization increasing with
the number of disorders (Kroenke, Spitzer,
Williams, Monahan, & Löwe, 2007). However,
screening tools are available. The Brief
Symptom Checklist-18 (Derogatis, 2001)
is a screening tool for both anxiety and
depression, and My Mood Monitor (M-3;
Gaynes et al., 2010) is a valid and efficient 
one-page tool for screening multiple common 
psychiatric illnesses in primary care and
other settings. The M-3 can function both as a
screen for specific anxiety and mood disorder
diagnoses and as a general screen for the
presence of any mood or anxiety disorder. 
Interventions such as passive
psychoeducation, including bibliotherapy,
have been shown to reduce symptoms
of anxiety, psychological distress, and
depression (Donker, Griffiths, Cuijpers, &
Christensen, 2009). These approaches may be
offered as a BI to patients who screen positive
for mild or moderate levels of anxiety.
Passive psychoeducational interventions are
cost effective, can be easily put into practice
by nonmedical professionals, and may have
a less prejudicial impact on consumers,
especially when delivered through a Web site,
email, or brochure (Donker et al., 2009). 
Psychological Trauma 
Evidence of emotional trauma is also common 
in primary care. Walker, Torkelson, Katon,
and Koss (1993) report that rates as high
as 37 percent for childhood sexual abuse
and 29 percent for adult sexual assault are
evident in primary care settings. Walker et
al. found that 61 percent of women reported
that they believed that it was appropriate
for their primary care physician to ask about
previous victimization, but only 4 percent
had been asked. Tools for screening trauma
and anxiety include the Trauma Symptom
Inventory (Briere, 1995) and the PTSD-8
(Hansen et al., 2010) and Primary Care PTSD 
Screen (PC-PTSD; Prins et al., 2003) for









A Model Framework 
Program implementation of screening,
brief intervention, brief treatment, and 
referral to treatment (SBIRT) services
depends on a variety of factors, including the
treatment program setting, available system
resources, State and other service systems
requirements, and organizational structure.
Exhibit 3-1 provides a framework for SBIRT 
and illustrates the multidimensional nature 
of SBIRT implementation. 
The model provides a pictorial reminder
of the overarching who, what, and where 
questions that must be considered during
SBIRT implementation planning: 




























































SBIRT Model Matrix 
• Service delivery—What SBIRT services 
will be delivered? What risk factors will be 
assessed? 
• Implementation model—How will 
services be provided? Who will provide
what services? How will staff be paid? 
• Settings—What are the unique
characteristics (and challenges) of the
program? Who are the target populations?
Where and how can they best be reached? 
This chapter offers general steps to
implementing SBIRT and discusses a range
of considerations, options, and questions
for each step. The steps were derived
and adapted from several sources: the
American Public Health Association and 
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Note: “ATOD Use” refers 
to combined alcohol, 
tobacco, and drug use. 
“ATOD Use +” refers to 
alcohol, tobacco, drug 
use, and other behavioral 
risk factors (e.g., poor 
diet, physical inactivity). 
Source: Babor & McRee 
(2006). 
















Education Development Center, Inc. (2008);
Henry-Edwards, Humeniuk, Ali, Poznyak, 
and Monteiro (2003); and Kleinschmidt
and Forman (2009). See Technical
Assistance Publication 31, Implementing 
Change in Substance Abuse Treatment 
Programs (Center for Substance Abuse
Treatment, 2009), for general information on
implementing change at the program level. 
Initiate the Planning Process 
and Develop Collaborations 
and Partnerships 
Assess Organizational Readiness 
for Change 
Organizations differ in their capacity to
implement new practices. Several factors—
staff workload, organizational structure and
culture, financial considerations—help or
hinder successful implementation of SBIRT
programs within a system of care. As does
any evidence-based practice, implementation
requires careful planning, flexibility to adapt
to new programs, and the structure necessary
to ensure fidelity with SBIRT. 
Bohman et al. (2008) evaluated a new measure
to gauge organizational readiness for change
during the implementation of an SBIRT
program at a trauma hospital emergency
department (ED) and three community health
program sites. The new measure, the Medical
Organizational Readiness for Change (MORC)
scale, was adapted from the instrument,
Organizational Readiness for Change (ORC;
Lehman, Greener, & Simpson, 2002). The new
measure includes multiple scales, comprising
18 content domains in four key areas: 
• Motivation for change (e.g., perceptions
of current functioning, needs for
improvement) 
• Institutional resources (e.g., adequacy of
office space, staffing) 
• Attributes of staff members (e.g.,
confidence in counseling abilities,
adaptability) 
• Organizational climate (e.g., clarity of
mission, staff cohesiveness) 
The evaluation found differences in readiness 
to change between clinical staff and
administrative staff and between EDs and 
community healthcare clinics. The MORC
scale helps an organization understand
its operations, focus on its strengths when
implementing strategies, tailor strategies
to different settings, and guide the
implementation process. 
Involve as Many Staff Members as Possible 
The support of management and stakeholders
is important to implementing SBIRT,
regardless of setting. In addition, staff
members are more likely to invest in SBIRT
implementation if they are involved in
planning from the start. In a small system
(e.g., a primary care practice), it may be
best to involve all staff members in the 
process. In a large system (e.g., a hospital
system), an important first step is identifying
appropriate planning participants from
among service components. Who are the 
primary stakeholders? Who has useful skills 
and experience? Involving staff members
from a range of disciplines and experiential
backgrounds facilitates effective planning. 
Washington State SBIRT 
Cohort 1 State Grantee 
The Washington State Division of Alcohol and Substance Abuse joined forces with a number of 
partners, including the Governor’s Office, the Department of Social and Health Services Medical 
Assistance Administration, the Department of Health, participating counties and hospitals, chemical 
dependence treatment providers, and a broad range of policymakers who are represented on the 
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Assess What Is Needed 
A careful assessment of current system
resources (both physical and personnel) can
save time and money. Is it possible to use 
existing staff members to provide at least 
some SBIRT services? If so, what training will 
they need? If not, for what SBIRT services 
must new staff members be hired? What 
qualifications must they have? Is existing 
space adequate, or can space be reconfigured 
for more privacy? 
Set Clear Goals 
It is important to know exactly what is to be
accomplished and within what timeframe. 
What is realistic given the resources available 
or that can be obtained? 
Assign Clear Roles and Responsibilities 
Appointing one staff member as the SBIRT
coordinator may be helpful. This person can
ensure that all staff members understand 
their roles and responsibilities and that all
necessary planning tasks are completed. 
Develop Collaborations and Partnerships 
Collaboration is critical, no matter the size 
of a system. System (or program) leaders
should identify potential public and private
collaborators and partners early on and begin
developing relationships. 
For example, the SBIRT team at the
University of Hawaii at Manoa developed
collaborations with the following university
departments and organizations: 
• Clinical and Health Promotion Services 
• Student Housing 
• Judicial Affairs 
• Counseling and Student Development
Center 
• Athletics Advisors 
• Sexual Assault Task Force 
Identify the Settings for 
SBIRT Services 
Hospitals, EDs, trauma centers, primary care
offices, and community health centers are
obvious settings in which to initiate SBIRT.
The American College of Surgeons (2007)
now requires Level I and Level II trauma
centers to establish mechanisms to identify
patients who have drinking problems.
However, SBIRT services are provided in a
much wider range of settings. Exhibit 3-2 
provides examples of other settings in which
Substance Abuse and Mental Health Services 
Administration (SAMHSA) grantees have
implemented SBIRT services. 
Questions to be answered when choosing a
setting include: 
• Who is the target population? 
• What is the patient flow? 
• In what type of setting are patients most
likely to be reached? 
• Is the setting/facility accessible to the
target population? 
• What resources are available? 
• Can partnerships expand screening
options? 
• Does the potential facility allow for privacy
and secure record storage? 
Exhibit 3-2. Selected SAMHSA SBIRT 
Grantee Service Settings 
Federally Qualified Health Center 
Public health department office 
High school-based clinic 
Planned Parenthood office 
Specialty health clinic (e.g., women, 
adolescents) 
Senior nutrition program 
Senior center 
HIV and sexually transmitted diseases clinic 
Tribal clinic 
College/university student union kiosk 
College/university athletic department, 
counseling center, health clinic 
Systems-Level Implementation of Screening, Brief Intervention, and Referral to Treatment
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Bristol Community College (Fall River, MA), CORE 
College and University Grantee 
One of Campus Outreach and Resource Enhancement’s (CORE’s) challenges was that student 
participation in CORE was 100-percent voluntary. In addition, available campus health services were 
limited at the start of the project. With no mandate to participate and the majority of students not 
identifying drug or alcohol use as a problem, project staff had to effectively motivate students to 
participate. Providers had to find students willing to participate and a location where feedback could be 
provided confidentially. A particularly successful situation was to offer screening and brief intervention 
(BI) to new students who were on campus for placement testing and meetings with academic advisors 
before the start of the semester. Because testing took place in a group format as well as in one-on-one 
encounters, students had a considerable amount of free time and could meet with CORE staff members 
outside of classes. 
Outreach was accomplished through classroom presentations, health and wellness events in the student 
center, and special events during which CORE had a strong presence. The activities provided a social 
marketing function with a strong prevention message and were successful in opening a dialog on 
campus about the use of drugs and alcohol by students and in the broader community. 
Select a Staffing Model 
Studies of SBIRT programs have shown good
results with a variety of staffing models.
Cost-benefit analyses suggest that some 
functions may be performed as equally well
(and at lower costs) by midlevel or support
staff as by senior staff. 
Where understaffing is a problem, community
workers or others not on staff may administer
some or all parts of an SBIRT program. For
example, a trauma center may contract with
a nearby substance abuse treatment provider
to conduct screening and intervention.
Alternatively, a designated staff person may
be hired and trained to conduct screening. 
The cohort 1 cross-site (C1) evaluation team
identified three basic implementation (or
staffing) models appropriate for SBIRT
services delivery: in-house generalist (IHG),
in-house specialist (IHS), and contracted
specialist (CS). 
In-House Generalist 
An IHG is a staff member who is trained to 
perform SBIRT functions in addition to his or
her regular job functions (e.g., a triage nurse
in an ED, a health educator in a community
health clinic). Such a person is not a
substance abuse treatment professional. 
Using an IHG to perform screening and
BI can be effective and can offer important
benefits. Patients may already have a
relationship with or be familiar with the
IHG. Moreover, when a medical staff member 
addresses substance abuse, behavioral 
recommendations can be tied to the patient’s
health or medical problem. This specificity
may help the patient feel less shameful or
uncomfortable talking about substance abuse. 
The generalist model poses certain
limitations, however. For example,
generalists often do not have the time to
perform SBIRT. Even very brief encounters
can impinge on other crucial functions.
However, screening does not necessarily take
a lot of time. Results from the C1 evaluation 
indicate that, regardless of the staff position
of the person performing SBIRT services (e.g.,
physician, nurse, counselor), the duration of
initial screening ranged from 2 to 5 minutes. 
Other limitations might include staff
members who are uncomfortable with 
people who misuse substances or who
lack confidence in their ability to perform
SBIRT functions. In training hospitals, high
physician turnover results in the need for
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Lessons learned from SAMHSA SBIRT 
grantees provide insights into effective ways
to overcome the challenges of an IHG model: 
• Implement SBIRT in ways that minimize
the time burden for staff. 
• Develop strong “champions” of SBIRT. 
• Provide time for staff to “buy into”
activities. 
• Provide adequate training, ongoing direct
supervision and monitoring, and regular
feedback. 
• Institute SBIRT training as a regular part
of employee orientation. 
• Collect and share aggregate and
patient-level outcomes data so that staff 
members can see the help they provide to
patients. 
• Combine SBIRT with other behavioral 
interventions (e.g., smoking cessation). 
In-House Specialist 
An IHS provides only SBIRT services,
freeing regular staff members from having
to conduct SBIRT activities. A program
may hire someone who is already trained
in SBIRT or may train a person already on
staff. This model can be efficient because 
few people need to be trained (or none, if an
already-trained specialist is hired specifically 
for SBIRT), and it provides consistency
because only a specific person or people
perform SBIRT activities. 
SAMHSA grantees using this model
encountered several challenges. EDs
or trauma centers can be difficult work 
environments for nonmedical staff, 
occasionally leading to turf wars between
medical and nonmedical staff. In-house 
supervision and management issues can
arise regarding ED staff supervising a
person without ED skills. SBIRT specialists
reported the expectation from ED staff that
they conduct non-SBIRT activities. Very
clear organizational structures need to be
in place to prevent these types of problems. 
Finally, the SBIRT model is not accepted by
all substance abuse treatment specialists.
Careful hiring practices ensure that specialist
staff members are trained in SBIRT and will 
provide services with fidelity. 
Contracted Specialist 
A third model for SBIRT is an outside 
provider who conducts SBIRT services.
This model has the advantage of providing
specialized, informed professionals dedicated
to conducting SBIRT, relieving regular staff
members of the additional time burden and 
providing a seamless integration of different
SBIRT components. 
There also are challenges to implementing
this model. A CS may not be fully integrated
into the team and may need time to become
familiar with the organizational culture,
the setting, and other staff members. This
situation can be particularly challenging for a
CS working in a hospital or trauma center for
the first time. A CS may find working in EDs
difficult; these settings differ greatly from
substance abuse treatment facilities. Finally,
insurance reimbursement for SBIRT in a 
medical setting can be a problem. Insurance
companies may be reluctant to pay for
services not directly related to a hospital stay
or for services provided by nonmedical staff. 
Staffing Models and SBIRT Grantees 
SBIRT grantees often used blended models
for multiple service components (e.g., IHG
for prescreening or screening, CS for BI or
brief treatment [BT]). All SBIRT grantees
migrated toward CS models for most
components of treatment delivery, both to
increase the number of patients screened and
to reduce the burden on medical staff. The CS 
model was successful across settings. 
An advantage of the CS model is that staff
members were less likely to stop SBIRT
services when the broader organization got
very busy. A potential disadvantage is that,
although the CS model is a viable approach
in high-volume settings, it may not be ideal 










in settings with a small number of patients
because there may be insufficient patient
flow to justify having a dedicated SBIRT
specialist. 
Regardless of which staffing model grantees
implemented, they used a wide variety
of professionals and paraprofessionals to
provide SBIRT services: nurses, physicians,
nurse practitioners, physician assistants,
social workers, psychologists, certified or
licensed addiction professionals, health
educators, hospital interns and residents,
school counselors, and others. 
Develop a Staff Training and 
Supervision Plan 
Because SBIRT occurs outside traditional 
substance abuse provider systems, training
for all staff members is critical. Effective 
training includes the following topics: 
• Importance of the SBIRT program 
•	 Efficacy of SBIRT as demonstrated in
clinical trials 
• Implementation procedures to be used 
• Staff roles and functions 
• Administration of screening tests and
calculating scores (including role-playing
and supervised practice) 
• Providing screening feedback to patients 
• Referral collaborations and procedures 
• BI and BT techniques if staff members will
be providing these services 
Staff members providing BIs and BTs must
be thoroughly trained in the evidence-based
clinical model employed and have access to
onsite or contracted supervision. All training
should include role-playing and supervised
practice so staff members are comfortable
performing BI and BT and perform them
with fidelity. The staff training plan should
institutionalize ongoing training for all
staff members and tie the training to staff
supervision and individual needs. 
SBIRT programs can obtain training
for staff members through a number of
combinations. For medical professionals,
continuing education units and continuing
medical education units are available through 
organizations such as the American Medical
Association; some units are available online. 
SAMHSA and its partners host trainings at
national and regional professional events.
(See Appendix B for training resources.) 
InSight, Harris County Hospital System (Houston, TX) 
Cohort 1 State Grantee 
InSight used a brief motivational intervention (BMI) approach for screening, intervention, and followup. 
BMI specialists received thorough training in motivational interviewing (MI). Training included a 2-day 
workshop on the principles and techniques of MI followed by standardized patient training (SPT). SPT 
enables trainees to practice skills using scripted mock sessions with trained actors as “clients.” An 
expert coach observed these sessions, then provided immediate feedback. Trainees practiced targeted 
skills in subsequent mock sessions. 
Expert coaches also provided BMI specialists with ongoing supervision and review of audiotaped 
sessions with real patients. Review of taped sessions included standardized MI behavior coding* and 
monthly feedback to specialists. This monitoring and feedback process helped ensure continued growth 
of specialists and fidelity to the MI model. For more information on the MI coding system, see Miller, 
Moyers, Ernst, and Amrhein, 2008. 
* Behavior coding is an objective and detailed method of providing skills feedback. The reviewer codes instances of specific 
behavior, such as “affirming” or “supporting autonomy.” 








Chapter 3―SBIRT Implementation 
Training can be arranged through
organizational collaborations. For example,
the Washington Division of Alcohol
and Substance Abuse contracted with 
nationally recognized trainers from the
University of Washington’s Harborview
Medical Center and the Northwest Frontier 
Addiction Technology Transfer Center to
provide training on BI and MI counseling.
Other grantees, such as the New Mexico
Department of Health, found creative
solutions to providing ongoing training and
monitoring through partnerships with local
universities and teletraining to multiple sites. 
All grantees contracted clinical training and
monitoring services through expert trainers.
Contracted trainers typically conducted
initial training that lasted from several
days to 1 week, depending on the model
and expertise of staff, and often provided
followup training or consultation. Some
grantees used trainers for several weeks
during a year, whereas others employed
them full time. Grantees with many rural
sites used more contracted trainers than did 
those concentrated in one or two large EDs.
Grantees also used onsite clinical supervisors 
to reinforce training and to monitor daily
performance of SBIRT staff. 
Develop a Screening Procedure 
The screening procedure needs to ensure
that screening is timely, systematic, and
efficient but also provides enough flexibility
to allow staff members to make the most of 
unexpected opportunities for screening. A first
step in developing a screening protocol is to
decide who will be screened. Will screening 
be universal? Will prescreening be used? Will
only a subset of the population be screened? If
so, how will these patients be identified? Do 
screening priority guidelines need to be set? 
What is realistic given the program’s resources? 
Once the population for screening has been
identified, the frequency of each person’s
screening must be considered: Will patients 
be screened at every visit or at regular 
intervals? When during a patient’s visit will 
screening occur? 
SBIRT programs also need to decide for what
they will screen. Risky/harmful alcohol use?
Illegal drug use? Prescription medication 
New Mexico Department of Health SBIRT: Sangre de Cristo Site 
Cohort 1 State Grantee 
A project goal was to create, in conjunction with the Governor’s Commission on Telehealth, a statewide 
telehealth system to support SBIRT, particularly in rural areas. The initial phase of the project was to use 
telehealth technology to: 
• Provide clinical supervision of the SBIRT behavioral health counselors (BHCs). 
• Conduct clinical staffing discussions and consultations regarding patient care. 
• Provide continuing professional clinical education to the New Mexico SBIRT BHCs and the New 

Mexico SBIRT partner site clinical providers and staff members.
 
Massachusetts: Heywood Hospital SBIRT Site 
Cohort 2 State Grantee 
This site implemented a protocol that allows ED triage nurses to ask prescreening questions and refer 
patients to the health-promotion advocate (HPA), the staff member who provides SBIRT. When patients’ 
answers to prescreening questions indicate a potential for alcohol and/or drug abuse or high-risk/ 
dependent behavior, the patients’ names are sent to the HPA. Although universal screening remains the 
norm at this site, prescreening by the triage nurse identifies patients who most need to be seen during 
their ED visits. 

































misuse and abuse? Tobacco use? Patients in
the SAMHSA SBIRT study abused a wide
range of prescription medications and illicit
substances. Many individuals who reported
consuming large quantities of alcohol also used
illicit drugs. The C1 evaluation team found
that screening for drug use can be combined
with screening for tobacco and at-risk use of
alcohol in a broad range of general medical
settings. Because multiple drug use is
common, screening for multiple substances
improved efficiency, resource allocation, and
clinical intervention/treatment. 
In addition to screening for alcohol and drugs, 
SBIRT programs can include other health
issues (e.g., eating disorders, depression) in
the screening or combine screening for alcohol 
and drug use into existing screening protocols
for health issues. 
How patients will be screened is an important
consideration. Several self-report screening
instruments are available. Self-report 
instruments that measure substance use are
generally reliable, but present some problems.
Accuracy depends on the patient’s perceptions
of potential negative consequences for truthful
responses (e.g., criminal sanctions, physician
disapproval, implications for insurance,
child welfare involvement). Patients may
intentionally misrepresent their drinking and
drug use if they fear consequences. Memory,
cognition, and motivation also play roles in a
patient’s ability to understand and participate
in screening. 
Despite these limitations, self-report
instruments have many benefits. Compared
with biological tests, they generally take less
time and training to administer. Screening
tests range from brief, straightforward
questions that can be administered in 1 or
2 minutes to those requiring more time and
training and/or professional licensure. One
screening tool is a single question, “How
many times in the past year have you used an
illegal drug or used a prescription medication
for nonmedical reasons?” (Smith et al., 2009;
Smith et al., 2010). This question is also
included in the NIDA Quick Screen, the first 
question of the NIDA Drug Use Screening
Tool. Exhibit 3-3 is an alphabetical list of 
commonly used screening instruments. These
instruments can be used as pen-and-paper 
or electronic self-report tests or as
clinician-administered questions. 
Some evidence suggests that the mode of
administration affects the accuracy of results.
For example, Graham, Goss, Xu, Magid, and
Diguiseppi (2007) found that administering
the AUDIT-C electronically was more
likely to identify hazardous drinking than
assessment via the paper version. 
Exhibit 3-3. Selected Screening Service Instruments 
• Alcohol, Smoking, and Substance Involvement Screening Test (ASSIST) 
• Alcohol Use Disorders Identification Test (AUDIT) 
• AUDIT-C 
• CAGE (Cut down, Annoyed, Guilty, Eye-opener) 
• CRAFFT (Car, Relax, Alone, Forget, Family or Friends, Trouble) 
• Drug Abuse Screening Test (DAST) 
• DAST-A 
• Fagerstrom Test for Nicotine Dependence 
• Michigan Alcohol Screening Test (MAST) 
• NIDA Drug Use Screening Tool 
• Problem-Oriented Screening Instrument for Teenagers (POSIT) 
• TWEAK (Tolerance, Worried, Eye-openers, Amnesia, [K] Cut down) 
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SBIRT program administrators can maximize
cost savings and effectiveness of screening
components through careful selection of
screening instruments. Short, simple screens
can identify hazardous use or dependence as
accurately as longer, more complex screening
tools and at a lower cost. More than 25 
validated self-report screening tools are now
available (Babor et al., 2007). These tools,
alone or in combination, identify risk level of
use and guide followup decisions. 
When selecting a screening instrument, some
important questions are: 
• What are the key characteristics of the
target population (e.g., age, level of
literacy, cognitive functioning)? 
• What is the percentage of patients who
cannot self-administer the tool? 
• What languages do patients understand? 
• How much time is available for 
administering and scoring the instrument? 
• Should a staff person administer
the instrument, or should patients
self-complete it? 
Test administrators must consider the 
number of questions in a screening
instrument. Long, time-consuming 
questionnaires may be unrealistic to
use. Instruments that have just one or
two questions may not provide enough
information. 
SBIRT programs also need to determine
screening followup procedures. Who will 
interpret the results and provide the patient 
with feedback? How will a patient be referred 
to BI, BT, or more intensive specialty 
treatment if screening is positive? 
Develop BI and BT Procedures 
Questions to consider regarding BI and BT
include: 
• Where and when will BI and BT occur, 
onsite or by referral to specialty substance
use disorder (SUD) treatment programs? 
• If BI or BT will be provided onsite, who
will provide these services? 
• What educational materials will be used? 
• What community resources need to be
tapped? 
• What training will staff members need? 
SBIRT programs also need to decide on
what clinical models (or combination of
models) and BI and BT techniques are most
appropriate and feasible. Traditionally,
BIs have been provided as a stand-alone
treatment to patients with less severe SUDs.
Recent evidence suggests, however, that BIs
can be effective with a range of patients. 
Models for BI include: 
• Brief Negotiated Interview (see Appendix
B) and simple advice. 
• Brief counseling. 
• FRAMES (Feedback, Responsibility,
Advice, Menus of options, Empathy,
Self-efficacy). 
• MI techniques. 
State University of New York, University at Albany 
College and University Grantee 
The university’s SBIRT initiative targets first-year students, student athletes, and students who seek 
health-related services at the University Health Center. Students are asked to log into a secure Web 
site to enroll in the SBIRT project and complete questionnaires. Data from the questionnaires are 
downloaded to a spreadsheet and used to create a personalized feedback sheet. Students who screen 
positive and receive BI, BT, or intensive specialty treatment receive an email with a Web link to followup 
questionnaires at discharge and at 6 weeks and 6 months after the intervention. 
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BT is frequently a stand-alone first treatment
but also can be useful for patients who
have undergone traditional treatment but
relapsed, as an alternative to longer-term 
treatment when patients cannot afford
treatment, or while patients wait for
specialized SUD treatment. 
Commonly used models for BT include: 
• Cognitive–behavioral therapy. 
• Motivational enhancement therapy. 
• Community reinforcement approach. 
• Solution-focused therapy. 
Appendix B identifies resources for more
information about clinical models. 
Develop Referral Procedures and 
Identify Referral Resources 
Research suggests that BI or BT alone
will not suffice for people who are severely
dependent on alcohol or drugs (Babor et al.,
2007) or who have co-occurring disorders
(e.g., depression, conduct disorders) (Fleming
& Graham, 2001). Some patients who meet
criteria for substance abuse/dependence
need referrals to more intensive specialty
treatment and mutual-help groups, such 
as Alcoholics Anonymous, Narcotics
Anonymous, Women for Sobriety, or SMART
(Self-Management and Recovery Training). 
SBIRT programs should develop referral
procedures that both motivate patients to 
enter treatment and connect them with 
convenient, accessible specialty treatment
programs. SAMHSA grantees found many
innovative ways to facilitate treatment entry: 
• Initiation of onsite treatment (at the
screening facility) 
• Provider-initiated appointments 
• Peer/mentor health educator support 
• Case management services 
• Transportation to treatment facilities 
• Negotiation for dedicated treatment slots
for SBIRT patients 
Most SBIRT grantees contracted with
community specialty providers to facilitate
referral processes. Prearranged referral
relationships ensure smooth transitions for
patients at the appropriate level of care and
facilitate followup. Cultivating collaboration
across systems—such as medical, SUD
treatment, mental health service centers, 
and criminal justice—is important for
successful implementation. Most grantees
developed referral relationships with a range
of community treatment resources to ensure
that referrals were appropriate to patients’
needs and cultural backgrounds. 
Develop a Recordkeeping 
Procedure and Evaluation Plan 
Patients’ participation in SBIRT should be
indicated in their records; some programs 
Massachusetts: Mercy Hospital SBIRT Site 
Cohort 2 State Grantee 
SBIRT patients have priority for service at Mercy Hospital. The hospital SBIRT program has working 
relationships with social workers from other area hospitals and ongoing relationships with SUD 
treatment providers from western to central Massachusetts. The program is a member of the Western 
Massachusetts Substance Abuse Providers Association and the Massachusetts Organization for 
Addiction Recovery. SBIRT staff members have toured many sites to which they refer patients and have 
met with nearly every admissions director and coordinator for those programs. Referral relationships 
include local counseling agencies, transitional programs, the Department of Public Health regional 
office, Healthcare for the Homeless and other nonprofit healthcare sites, detoxification hospitals, and 
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attach a colored sticker to the paper record.
Patient-level information essential to 
effective patient care and program evaluation
includes: 
• Initial screening scores. 
• Interventions undertaken. 
• Progress notes. 
• Referrals made. 
• Followup screening scores/outcomes and
treatment utilization. 
• Physical and mental health symptoms or
diagnoses. 
• Next scheduled screening. 
Evaluation is critical to SBIRT sustainability.
Process and outcome evaluations can guide
change, encourage staff members, and provide
justification to funders. SBIRT program
personnel should begin to research evaluation
strategies early in the SBIRT implementation
process, including considering possible
State, regional, and local partners, such as
universities. The following organizations
or associations provide information about
evaluation (see Appendix B): 
• American Evaluation Association 
• Centers for Disease Control and 
Prevention 
• Innovation Network 
• Network for the Improvement of Addiction
Treatment 
• University of Wisconsin Cooperative
Extension course: Enhancing Program
Performance with Logic Models 
• W. K. Kellogg Foundation 
Providing regular feedback of evaluation
results to all participating staff members
is essential for ongoing improvement of the
program and for maintaining staff motivation
and commitment to the program. Ongoing
feedback from staff is also important;
it provides information about how the
implementation processes are working,
identifies problems early in the process, and
generates ideas for improvements. 
SBIRT grantees typically contracted with
external evaluators for monitoring and
assessing performance indicators. 
Develop a Funding and 
Reimbursement Strategy 
Funding and reimbursement are critical to
SBIRT program success and sustainability.
SBIRT program leaders should begin early
in the implementation process to identify
potential Federal, State, and private funding
resources and fully understand public and
private insurance reimbursement procedures
and issues. Program costs, reimbursement,
and sustainability are discussed in Chapter 4. 



















Barriers to and Facilitators of 
Successful SBIRT Implementation 
The cohort 1 cross-site (C1) evaluation team
noted three common themes associated with 
successful screening, brief intervention, brief
treatment, and referral to treatment (SBIRT)
systems-level program implementation: 
• Leadership and positive interagency
collaboration 
• Provider buy-in 
• Favorable setting and contextual factors 
Leadership and Positive Interagency 
Collaboration 
Grantees reported that competing missions,
values, procedures, and policies in each
referral agency led to communication
challenges and hindered successful
implementation. Grantees noted the following
helpful factors to overcome these challenges: 
• Positive interagency relationships,
including cooperation before and after
the implementation, collaboration,
communication, and leadership at all
levels 
• Strong leaders who delivered clear,
consistent messages about program goals
and values and encouraged communication
among key stakeholders 
• At least one person at each level who
championed SBIRT 
Provider Buy-in 
Staff resistance to a new program is common.
Grantees reported that some generalist
providers in medical settings had difficulty
shifting their attention from patients’ 
physical conditions to also focusing on
patients’ nondependent, risky substance use.
Generalists may also be inexperienced in
using motivational interviewing techniques
and incorporating behavioral health practices
in medical care settings. Further, grantees
reported that generalist providers were
reluctant to add procedures to their already
busy schedules. 
Grantees indicated the following helpful
factors: 
• A planning and development phase that is
long enough for program directors to elicit
and secure the support and cooperation of
personnel at all organizational levels 
• Staff members at all levels of planning
who help obtain support for the program
(In particular, grantees noted that support
from senior leaders, such as onsite 
physicians and nurses, was a critical
element for success.) 
• Standardized staff training 
Grantees’ experiences provided additional
ideas for overcoming staff resistance: 
• Teach staff members about alcohol and 
other substance use disorders (SUDs) and
the cost effectiveness and health benefits of 
SBIRT. 
• Provide specific and ongoing training. 
• Design programs that minimize the time
burden for onsite staff. 
• Elicit support from opinion leaders. 
• Establish program goals and provide
ongoing feedback and incentives to staff
members. 
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• Create in-house, interdisciplinary teams to
formulate policies and procedures. 
• Use alternative screening procedures, such
as electronic screening instruments, that
are effective with some populations and
save staff time. 
Contextual Factors 
Grantees noted a number of contextual 
factors that facilitated SBIRT 
implementation, including: 
• Useful available technology (e.g., video
or telephone intervention and treatment
services). 
• Screening and other data collection tools
to supplement existing assessment and/or
enhance electronic health records. 
• Short screening or prescreening tools. 
However, grantees noted a lack of physical
space for the delivery of SBIRT services as a
barrier to implementation, leading to lack of
privacy (e.g., administering the screening in
the patient waiting room, hallway, or other
public area), particularly in high-volume
settings (e.g., emergency departments [EDs],
trauma centers). This lack of privacy led to
concerns about confidentiality and patients’
rights (see Confidentiality, below). 
Confidentiality 
Privacy can be difficult to maintain in busy
healthcare settings, especially in a busy
ED with only a curtain separating patients.
However, care needs to be taken to provide
privacy during screening. 
The Federal Health Insurance Portability
and Accountability Act (HIPAA) contains
strict provisions for guarding patient records,
regardless of setting. Another regulation,
42 Code of Federal Regulations (CFR) Part
2, specifically protects the privacy of people
seeking treatment for substance abuse.
This regulation applies to organizations
that provide any type of substance abuse 
treatment services in any component of the
organization and receive direct or indirect
Federal monies (including Medicare or
Medicaid). For resources providing more
information about 42 CFR Part 2 and HIPAA, 
see Appendix B. 
Uniform Accident and Sickness 
Policy Provision Law 
The Uniform Accident and Sickness Policy
Provision Law (UPPL) poses a significant
barrier to SBIRT in many States. First
enacted in 1947, the law allows insurance 
companies to deny payments to individuals
injured while under the influence of alcohol.
To deny reimbursement, the insurer must
demonstrate that alcohol to some degree
caused the insured person’s injury or other
medical problem. Recently, several States
have moved to repeal these laws, and some
States have regulations explicitly prohibiting
insurers from denying payment for medical
costs resulting from the intoxication of the
insured. Some States do not have UPPLs 
but implicitly allow insurers to use alcohol
exclusions by ruling that, in the absence
of explicit laws, insurance companies may
include alcohol exclusions in policies to limit
liability (Fornili & Goplerud, 2006). 
Some healthcare providers are reluctant to
screen patients for SUDs because they are
concerned that the patient’s health insurance
carrier may deny reimbursement for the
visit if an alcohol problem is identified. This
may be especially common in EDs because
of the risk that insurers will not reimburse 
for the treatment if the patient was under
the influence of alcohol or drugs (Gentilello,
Donato, et al., 2005; Rivara, Tollefson, Tesh, 
& Gentilello, 2000). Gentilello, Donato, et al.
(2005) reported that 24 percent of trauma
surgeons had encountered an insurance
reimbursement denial in the past 6 months
because of a patient’s alcohol or drug use.
Bloss, Chen, and Yi (2008) assessed the
frequency of substance abuse identification in
EDs and trauma centers in Maryland before
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They found a 20- to 34-percent increase in
the frequency of alcohol-related conditions
identified after the law was repealed. 
UPPL presents a barrier to SBIRT because
patients and/or providers may have to
absorb the cost of the treatment if substance 
abuse is identified. At this time, there is no 
solution to this problem other than working
toward repeal in States that have UPPLs.
The National Institute on Alcohol Abuse 
and Alcoholism’s Alcohol Policy Information
System provides information on States
with and without UPPLs (see Appendix B).
Anderson, Aromaa, Rosenbloom, and Enos 
(2008) suggest that when hospital, ED, or
trauma center staff dedicated to providing
SBIRT services collect information about 
a patient’s substance use (such as during
SBIRT screening), the specific information
gathered may be protected under 42 CFR
Part 2 and may not need to be reported to
insurers. If, however, information is collected 
through medical tests (such as blood alcohol
levels or toxicology) to treat the patient, such
information is not protected from disclosure
to insurers. SBIRT providers should obtain
legal counsel before establishing policies on
UPPL provisions and confidentiality. In any
case, patients need to be informed of SBIRT
screening and provide their consent to be
screened. 
Reimbursement for SBIRT 
SBIRT costs vary greatly according to setting,
staffing model, and services offered. Looking
at staffing models, for example, the C1
evaluation team found that: 
• The in-house generalist (IHG) model had
the lowest annual operating costs and
could most likely be supported by revenues
from insurance reimbursement. 
• The in-house specialist model could be
supported by service-reimbursement
revenues if the specialist engages in other
(non-SBIRT) revenue-generating activities
and if training and administrative
management costs are contained. 
• The contracted specialist (CS) model
is likely to require State or local funds
in addition to service reimbursement 
revenues to be financially viable. The
extent to which the CS can engage in
non-SBIRT revenue-generating activities
greatly influences the model’s financial
viability. 
Reimbursement is available through
commercial insurance Current Procedural 
Terminology (CPT) codes, Medicare G codes,
and Medicaid Healthcare Common Procedure 
Code System (HCPCS) codes. 
Commercial Insurance and Medicare 
CPT is a numeric coding system maintained
by the American Medical Association (AMA).
Recognizing the potential health and cost
benefits of SBIRT, AMA instituted new 
healthcare codes specifically for substance
abuse screening and brief intervention. Four
codes can be used—two are for privately
insured patients (99408 and 99409), and
two are for Medicare patients (G0396 and
G0397). Fees are determined by the duration
of the screening and/or brief intervention. A
description of the four codes is as follows: 
• CPT 99408: Alcohol and/or substance
(other than tobacco) abuse structured
screening and brief intervention services,
15–30 minutes 
• CPT 99409: Alcohol and/or substance
(other than tobacco) abuse structured
screening and brief intervention services,
greater than 30 minutes 
• G0396: Alcohol and/or substance (other
than tobacco) abuse structured assessment
(e.g., Alcohol Use Disorders Identification
Test [AUDIT], Drug Abuse Screening Test
[DAST]) and brief intervention, 15–30
minutes 
• G0397: Alcohol and/or substance (other
than tobacco) abuse structured assessment
(e.g., AUDIT, DAST) and intervention,
greater than 30 minutes 

















Medicare will instruct its carriers to pay for
G0396 and G0397 “only when considered
reasonable and necessary.” 
Other codes may be used for SBIRT 
reimbursement, such as some codes for: 
• Alcohol and drug testing (biologic assays). 
• Psychotherapy. 
• Health and behavior assessment/
intervention. 
Additional information regarding Medicare
reimbursement is available in the fact sheet, 
Substance (Other Than Tobacco) Abuse 
Structured Assessment and Brief Intervention 
(SBIRT) Services. (See Appendix B.) 
Medicaid and Working With State Medicaid 
Agencies 
The Centers for Medicare and Medicaid 
Services Medicaid HCPCS billing codes for
screening and brief intervention are: 
• H0049: Alcohol and/or drug screening. 
• H0050: Alcohol and/or drug services, brief
intervention, per 15 minutes. 
However, each State must activate or unlock 
the HCPCS codes. In other words, the State 
Medicaid agency must agree to reimburse for 
the services. This process of unlocking codes
varies by State. State Medicaid systems are
complex, and sustained effort is required
to effect change in these systems. The C1
evaluation team found that many grantees
underestimated the difficulties of working
with their State Medicaid agencies. 
Historically, Medicaid did not consider
substance abuse a medical issue, and 
providers may have been resistant to
unlocking SBIRT reimbursement codes.
However, the Affordable Care Act (ACA; P.L.
111-148, as amended by the Health Care and
Education Reconciliation Act of 2010; P.L. 
111-152) includes substance use disorders
as “one of the ten elements of essential 
health benefits.” Beginning in 2014, all
health insurance sold on Health Insurance 
Exchanges or provided by Medicaid (to newly
eligible adults) will be required to include
substance use disorder treatment (Office
of National Drug Control Policy, 2012b).
These factors require State substance abuse
treatment agencies to use strategies that
stress the cost benefit of SBIRT and consider 
political realities. The ACA has created new
opportunities for SBIRT across a wide range
of healthcare settings, but implementation
challenges still exist. 
Medicaid Strategies: Washington State SBIRT Program 
Cohort 1 State Grantee 
Lessons learned from the Washington State SBIRT program suggest several strategies for working with 
the State Medicaid agency to unlock HCPCS codes for SBIRT (Gelber & O’Neil, 2007): 
• Understand how the State Medicaid agency works before attempting to influence it. 
• Develop talking points that explain SBIRT as a medically necessary activity. 
• Outline practice standards, provider types, and work units. 
• Frame arguments in terms of cost benefit or political expediency. 
• Do the homework, gather supporting data, and be prepared to perform followup analysis as needed. 
• Think broadly—focus on systems change. 
• Be prepared to drive the process. 
• Have a clear sense of mission. 
• Engage those with experience in implementing SBIRT. 
• Seek advocates at State and local levels. 
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Sustainability: Beyond 
Reimbursement 
The level of insurance reimbursement 
may not cover all SBIRT costs. More
important, not all patients are eligible for
reimbursement: the C1 evaluation team 
found that all sites had a high proportion
of SBIRT patients who were uninsured and
ineligible for Medicaid. Grantees’ financial
sustainability efforts include several
strategies: 
• Accessing State or local funding, including
convincing local hospital or treatment
agencies to support some services 
• Obtaining research and other grant
funding for ongoing support 
• Changing from a CS model to an IHG
model 
• Screening for substance use within the
context of a broad behavioral health 
screening protocol 
• Placing continuation funding in pending
State legislation 
The Florida grantee (cohort 2) developed a
sustainability guide for its partner agencies
that offers the following suggestions for
achieving financial sustainability (Florida
Brief Intervention and Treatment for Elders 
[BRITE], 2009): 
• Check Substance Abuse and Mental 
Health Services Administration and 
Department of Health and Human
Services funding announcements. 
• Explore State substance abuse program
funding (both prevention and treatment). 
• Be aware of funding available through
local departments of health, education,
justice, and corrections. 
• Check the Foundation Directory on the
Foundation Center Web site (see Appendix
B). 
• Ask stakeholders for donations and 
annuities. 
• Obtain external fundraising expertise. 
• Start a related for-profit or not-for-profit
business entity or product line that
contributes to programming. 
Sustainability entails more than financing.
Maintaining staff motivation and program
support at the organizational, local, and
State levels is crucial. Also critical are 
effective management, quality assurance,
ongoing training, program evaluation, and
communication among all involved. Exhibit
4-1 provides a list of eight key elements of
sustainability. 
Exhibit 4-1. Key Elements of Sustainability 
Element Tasks 
Vision • Know what is to be sustained: scope of activities, scale of operation, and timeline. 
• Know how the initiative fits within the larger community. 
Results 
Orientation 
• Adopt a results framework. 
• Clearly state the results to be achieved for the target population. 




• Determine expected fiscal needs. 
• Make the best use of existing resources (fiscal and in-kind). 
• Maximize available sources of revenue. 
• Create greater flexibility in categorical funding. 
• Create public–private partnerships. 
• Monitor announced opportunities for funding. 
• Explore State and local revenue sources. 
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• Consider new ways to frame the work to interest different funders. 
• Identify opportunities to improve the policy climate. 
• Participate in collaborative advocacy to encourage change. 
• Work to improve the organization’s ability to participate in these efforts. 
Broad Base of 
Community 
Support 
• Develop a plan to create a desired identity. 
• Nurture a community presence and support. 
• Encourage involvement of clients and recipients of services. 
• Support public education and engagement. 
• Build partnerships that foster collaboration rather than competition. 
Key 
Champions 
• Identify decisionmakers and opinion leaders. 
• Develop an effective outreach plan. 
 • Cultivate a broad base of champions: elected officials, business professionals, peers, 




 • Know and involve the people who carry out the organization’s mission: staff members, 
board members, volunteers, other interested parties. 
• Develop strong fiscal management, accounting, information, and personnel procedures. 
• Use those systems to review strategies and make changes as needed. 
Sustainability 
Plan 
• Develop a comprehensive plan that takes into account short- and long-term needs. 
• Identify challenges and barriers and address them. 
• Identify strategies to obtain needed resources. 
• Identify and communicate with key partners. 







Chapter 5—Case Examples: The Substance 
Abuse and Mental Health Services 
Administration SBIRT Grantee Experience 
This chapter discusses the experiences of the
cohort 1 grantees. The cohort 1 programs
were both geographically and clinically
diverse. Geographically, they spanned from
the East Coast to the West Coast of the 
United States and represented a range of
communities (e.g., rural, urban). Clinically,
they differed in the types of screening
instruments used, the types of professionals
who performed screening and offered brief
treatment (BT), and the number of BT
sessions offered. Clinical settings differed
as well, ranging from community health
centers, Indian Health Service clinics, and 
primary care clinics, to hospital emergency
departments (EDs) and ED trauma centers. 
Washington State Screening, 
Brief Intervention, Referral, and 
Treatment 
Program Overview 
The Washington State Screening, Brief
Intervention, Referral, and Treatment 
(WASBIRT) program was part of the
Substance Abuse and Mental Health 
Services Administration’s (SAMHSA’s)
cohort 1 cooperative agreement and was
implemented in 2004. WASBIRT placed 27
substance use disorder (SUD) professionals
in 9 of Washington State’s busiest hospital
EDs to provide frontline screening and
early identification of substance abuse
treatment needs. In the past, the State had
difficulty identifying individuals with SUDs
and providing them with access to prompt
treatment. Furthermore, individuals seeking
treatment encountered waiting lists. 
This project was operated by the State’s
Department of Social and Health 
Services’ Health and Recovery Services
Administration. The goals of the WASBIRT 
program were to: 
•	 Improve identification of patients coming
to the ED with SUDs. 
• Conduct screening and brief interventions
(BIs) in the ED. 
• Deliver BT on an outpatient basis at
certified treatment centers. 
• Increase referrals of people needing
specialty treatment. 
• Reduce ED utilization, medical costs, 
criminal behavior, substance-related 
disability, and death of patients with
alcohol or drug problems. 
• Improve links between hospitals and
treatment services and expand services to
include early intervention. 
The Process 
In the first 18 months, SUD treatment 
professionals used the Alcohol Use Disorders
Identification Test (AUDIT) to screen more
than 27,000 patients for substance use
problems. Forty-six percent of patients had
positive screening results for substance use
problems. Patients with positive results
received BIs or were referred for followup
treatment. About one-third of patients
approached declined to participate, were
too ill, or did not meet the selected criteria 
(e.g., were too young, spoke a language
for which the program did not have the
capacity to translate, were in police custody).
Five percent of patients had two screening
sessions, and 1 percent had three or more
sessions during the year. Depending on
screening results, patients were screened out,
provided BIs, referred for assessment and 
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brief therapy, or referred for assessment and
possibly full substance abuse treatment. 
Program Implementation 
Program leadership developed educational
tools for State hospital trauma coordinators,
enabling consistent training across the nine
sites. Program staff conducted site visits and
provided train-the-trainer sessions. 
An in-house generalist, such as the trauma
coordinator, led the program at each site.
These generalists supervised the counselors
who performed the screening. At each site,
a BI group directed policy and procedure
development and implementation. This group
included: 
• ED clinician 
• ED case manager 
• Hospital case manager/social worker 
• Trauma coordinator 
• Trauma medical director 
• Trauma billing representative 
• Chaplain services 
Implementation Challenges 
WASBIRT encountered some implementation
obstacles, such as limited resources for 
assistance, busy schedules, and pushback
from some provider groups. To overcome
these obstacles, the program identified and
positioned regional program representatives
who provided additional training to staff
members. This training convinced ED staff
of SBIRT’s usefulness. Support from service
directors and trauma medical directors was 
crucial in facilitating implementation. 
Six-Month Followup Survey 
During the baseline screening survey at
admission to the ED, patients who received
a BI and/or a referral to further treatment
were randomly selected for a followup
survey even if they did not engage in further 
treatment. The counselor obtained patient
contact information; then interviewers 
used administrative records to update and
supplement the information of patients who
gave permission to use their personal records
in the study. A staff member sent a reminder
letter 1 week before the followup interview.
An interviewer then attempted to contact
the person over a 3-month period, using
telephone calls and letters to the patient’s
alternate contacts as necessary. 
Between April 2004 and March 2006,
WASBIRT screened 34,762 patients.
SBIRT professionals provided at least a
BI to 52 percent of these patients based on
their screening results. Of the more than
15,000 patients who received at least a BI,
2,648 were randomly selected for followup
telephone interviews 6 months after the
intervention. Of those, 78 percent completed
the survey. 
The effects of receiving BIs on subsequent
substance use were positive. The average
days of reported recent alcohol and drug use
declined, and abstinence rates increased. 
Among patients who received at least a 
BI, substance use reported in the 6-month
followup interview changed significantly
compared with use reported at screening: 
• Of 1,398 patients who drank alcohol, 80
percent reduced the number of drinking
days (in the past 30 days), with the overall
average declining from 10.4 to 5.3 days
(p<0.05). 
• The percentage of patients reporting
abstinence from alcohol in the past 30 days
increased from 28 percent to 47 percent
(p<0.05). 
• Of 857 patients who reported binge
drinking (five or more drinks in one sitting
in the last 30 days), 87 percent reduced
the number of heavy drinking days, with
the average declining from 10.1 to 2.9 days
(p<0.05). 
• Of 878 patients who reported drug use in
the past 30 days, 84 percent reduced the
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average declining from 13.7 to 6.5 days
(p<0.05). 
• The percentage of patients reporting
abstinence from illicit drugs in the past
30 days increased from 55 percent to 71
percent (p<0.05). 
• Among patients with a high risk for SUDs,
declines in alcohol use and in illegal drug
use were significantly greater for those
who received BT or more intensive SUD 
treatment than for those who received only
BI. 
• Illegal drug use declined among high-risk
patients who used marijuana, cocaine,
methamphetamine, and heroin or other
opioids (p<0.05). 
• Among high-risk patients who used
marijuana, cocaine, or methamphetamine,
declines in overall drug use were greater
for those who also received BT or 
substance abuse treatment than for those 
who received only BI (p<0.05). 
New Mexico Human Services 
Department, Behavioral Health 
Services Division 
Program Overview 
In partnership with Sangre de Cristo
Community Health Partnership (SDCCHP),
the New Mexico Human Services 
Department, Behavioral Health Services
Division, used SAMHSA funds to establish 
a statewide SBIRT program focusing on
bringing integrated behavioral health and
medical care services to minority populations
in rural areas. Begun in 2004, the program
in New Mexico gradually expanded the model
to include school-based health centers, public
health offices, Indian Health Service units, 
and 1 rural hospital, for a total of 34 sites. 
The Process 
SBIRT activities were conducted by 24
master’s-level behavioral health consultants 
(BHCs). A clinical director and four regional 
supervisors provided supervision. Fidelity
was established through regularly scheduled
clinical supervision (both onsite and via
teleconference) and continuous training of
BHCs. 
Program Implementation 
The program provided pre-implementation
training in motivational interviewing (MI)
and the community reinforcement approach
(CRA) to BHCs. A basic training module for
clinic providers was developed that explained
the purpose of SBIRT, the work of the health
consultants, and approaches to integrating
SBIRT services into the primary care
services. 
The program emphasized early screening
and intervention at rural community-level
sites, such as community-based primary
care clinics, which were trusted by the
community. Program officials hoped that the
use of established and trusted sites would 
increase the comfort level of individuals being
screened. 
BI was provided immediately to all patients
who had a positive screening result. BHCs
provided feedback to patients about their
scores and engaged patients in conversations
about their health. The BT consisted of 6 
to 10 sessions of CRA. Those at very high
risk were referred by BHCs for intensive
treatment to specialized community agencies. 
New Mexico’s SBIRT program also
implemented a statewide Telehealth
Initiative that provides telecommunication
equipment and connection to 20 rural
partner sites. This infrastructure provides
supervision, training, and consultant
support to BHCs throughout the State.
The New Mexico program faced numerous
implementation challenges, including serving
several diverse populations and meeting their
needs in many large rural areas. 







Choosing and Cultivating Collaborators 
Lessons learned from New Mexico’s 
SBIRT program suggest that partnering
organizations should be assessed for their
readiness to change, most notably having the
support of key managers within agencies and
from staff members at all levels. New Mexico 
hosted an orientation meeting for potential
partners to determine which organizations
could participate. Each potential partner
organization was asked to complete an
Organizational Readiness Questionnaire
developed by the Texas Christian University
Institute of Behavioral Research. 
New Mexico’s recommendations for 
cultivating partnerships include the
following: 
• Use collaboration to select the appropriate
screening tools. Consider differences in
populations being served and staff and
patient time constraints. 
• Hold regularly scheduled meetings and
training sessions. 
• Develop memoranda of agreement between
partner sites and SBIRT management that
specify roles, responsibilities, program
targets, and outcomes. 
• Obtain support from clinic staff at all
levels at each site. Seek staff input on
organization and program changes. 
•	 Use financial incentives—To improve
cooperation, the New Mexico grantee
offered $20 to patients who completed the
followup. 
Flexibility and Fidelity 
Although New Mexico’s SBIRT
implementation team recognized the need to
adapt to regional and cultural differences,
staff members found working in a clinic
environment challenging. They revised
the implementation plan to better meet
the needs of different settings, situations,
tribal cultures, and staff backgrounds and
attitudes. 
The initial protocol also called for a 1- to
2-minute transfer in which the clinic’s 
physician introduced the patient to the
BHC. In busy clinics, however, this was not
feasible, so a very brief introduction was
substituted. 
Staff Training 
New Mexico’s SBIRT program hired
master’s-level mental health counselors 
and social workers as BHCs. Most BHCs 
did not have SUD treatment experience,
requiring ongoing training and supervision
by the SBIRT clinical director and regional
clinical supervisors. New employees were
trained in MI, CRA, or both. New Mexico’s 
SBIRT program invested significantly in the
training and clinical supervision of its clinical
staff. Because acquiring new skills, such as
MI, requires ongoing support and feedback,
the training process allowed for practice,
continual followup, and reinforcement.
The program developed training tools that
included tapes and checklists. 
Working With Native American Populations 
New Mexico’s SBIRT program worked with
three clinics operated by the Taos Pueblo,
Jicarilla Apache, and Zuni Tribes. Although
the contractual relationship was the same
across the three tribes, the level of staffing
varied by site. Working at these sites
required coordination with two additional
organizations, each with its own culture and
requirements—the Indian Health Service and
the specific Native American tribal council. 
Contractual Relationships 
In 2003, the New Mexico Governor’s 
Office restructured the State’s behavioral 
health services. Under the new system,
ValueOptions New Mexico (VONM) serves as
the funding passthrough entity for Federal
behavioral health grant dollars. In July 2005,
VONM assumed responsibility for contract
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New Mexico’s decision to implement its
project through a contractual agreement with
an independent agency (i.e., SDCCHP) had
significant advantages. The agreement: 
• Allowed for rapid implementation; the
project was running within 4 months. 
• Eliminated the need to work through State
bureaucratic systems, allowing for the
quick hiring of staff. 
•	 Offered the flexibility to implement SBIRT
at different sites simultaneously. 
• Freed program staff to develop and
implement the Telehealth network and
psychiatric consultation services through
the University of New Mexico’s Office of
Rural Psychiatry. 
• Allowed for the centralization of project
and patient data at the SDCCHP office,
supporting easy and timely access to data. 
Six-Month Followup Survey 
Data compiled over 20 months indicate more
than 19,000 patients in New Mexico were
screened. Some 1,817 patients reported
high-risk levels of substance use and received 
onsite BIs and BTs from SBIRT BHCs. Of 
these 1,817 individuals, 1,148 scored at 
“moderate risk” for alcohol- and drug-related
problems, 576 patients scored at “high risk”
for problems, and 93 scored at “very high
risk” for problems. 
Of the 1,817 individuals reporting some
high-risk level of substance use, at 6-month
followup: 
• Forty-seven percent of the patients had
decreased their alcohol use, and 29 percent
reported a decrease in drug use. 
• There was a 58-percent increase in
patients reporting no alcohol or drug use. 
• The number of days of drinking to
intoxication significantly decreased from
an average of 4.75 days at intake to 3.35
days at followup, a mean change of 1.4
days (p<0.01). 
• The number of days of drug use decreased
from a mean of 5.11 days at intake to a
mean of 2.62 days at followup, a mean
change of 2.5 days (p<0.01). 
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An 8-item screening tool 
developed for the World Health 
Organization (WHO) by an 
international group of substance 
abuse researchers to detect 
and manage substance use and 
related problems in primary and 
general medical care settings. 
Includes a patient feedback 




The Alcohol, Smoking and Substance 
Involvement Screening Test (ASSIST): 
Manual for Use in Primary Care







A 10-item screening tool 
developed by WHO to identify 
persons whose alcohol 
consumption has become 
hazardous or harmful to their 
health. Available in English-, 




AUDIT: The Alcohol Use Disorders 
Identification Test Guidelines for 
Use in Primary Care, Second Edition
http://whqlibdoc.who.int/hq/2001/ 
WHO_MSD_MSB_01.6a.pdf 
AUDIT-C Adults The first 3 questions of AUDIT 










older than age 
16) 
A 4-item, nonconfrontational 
questionnaire for detecting 
alcohol problems. Questions 
are usually phrased as “have 
you ever” but may also focus on 








Adolescents A 6-item screening instrument. 
Test covers alcohol and drugs 
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Adults A 20- and 28-item adaptation 
of the Michigan Alcohol 
Screening Test (MAST) to detect 
consequences related to drug 
abuse without being specific 
about the drug, thus alleviating 
the necessity of using different 
instruments specific to each drug. 
20-item instrument: http://adai. 
washington.edu/instruments/pdf/ 
Drug_Abuse_Screening_Test_105.pdf 
28-item instrument: http://www. 
projectcork.org/clinical_tools/html/ 
DAST.html 







Adults A 6-item test evaluating cigarette 
consumption, the compulsion to 
use, and dependence. Screens 
for nicotine dependence. Severity 












A 25-item instrument providing 
a general measure of lifetime 
alcohol problem severity that can 
be used for choosing treatment 
intensity and guiding inquiry into 
alcohol-related problems. A 13­
item version (Short MAST) and 
geriatric version (MAST-G) are 
available. 
Original MAST (Selzer, 1971) 










Adults A 1- to 7-question screening tool 
adapted by the National Institute 
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TAPs 1–18, 20, 23–27 are no longer available. 
TAP 19 Counselor’s Manual for Relapse Prevention With Chemically Dependent Criminal Offenders (SMA) 
06-4217
TAP 21 Addiction Counseling Competencies: The Knowledge, Skills, and Attitudes of Professional Practice
(SMA) 12-4171
 
TAP 21-A Competencies for Substance Abuse Treatment Clinical Supervisors (SMA) 12-4243
 
TAP 22 Contracting for Managed Substance Abuse and Mental Health Services: A Guide for Public 
Purchasers BKD252 
TAP 28 The National Rural Alcohol and Drug Abuse Network Awards for Excellence 2004, Submitted and 
Award-Winning Papers (SMA) 12-4183
 
TAP 29 Integrating State Administrative Records To Manage Substance Abuse Treatment System Performance
(SMA) 12-4268
 
TAP 30 Buprenorphine: A Guide for Nurses (SMA) 09-4376
 
TAP 31 Implementing Change in Substance Abuse Treatment Programs (SMA) 09-4377
 
TAP 32 Clinical Drug Testing in Primary Care (SMA) 12-4668
 
TAP 33 Systems-Level Implementation of Screening, Brief Intervention, and Referral to Treatment
(SMA) 13-4741
 
TAPs may be ordered or downloaded from SAMHSA’s Publications Ordering Web page at 
http://store.samhsa.gov. Or, please call SAMHSA at 1-877-SAMHSA-7 (1-877-726-4727) (English and 
Español). 
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